CA2667009A1 - Electrode markers and methods of use - Google Patents
Electrode markers and methods of use Download PDFInfo
- Publication number
- CA2667009A1 CA2667009A1 CA 2667009 CA2667009A CA2667009A1 CA 2667009 A1 CA2667009 A1 CA 2667009A1 CA 2667009 CA2667009 CA 2667009 CA 2667009 A CA2667009 A CA 2667009A CA 2667009 A1 CA2667009 A1 CA 2667009A1
- Authority
- CA
- Canada
- Prior art keywords
- energy delivery
- treatment
- delivery device
- tissue
- access device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/00267—Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
Abstract
An energy delivery device for treating tissue regions in a body conduit, such as a lung airway, may utilize one or more markers, rings, bands, or oth er visual indicators along an outer surface of the device body. The one or m ore visual indicators facilitate guidance of the device to effectively and e fficiently treat the tissue according to a predetermined axial treatment as well as measure extension of a distal portion of the device, tissue length, and/or treatment length. The predetermined axial treatment may be contiguous , overlapping, or intermittently spaced apart as determined by the marker sp acing distance.
Description
ELECTRODE MARKERS AND METHODS OF IJSE
BACKGROUND OF 'I'1-IE INVENTION
100011 Asthma is a disease in which bronchoconstriction, excessive mucus production, and inflammation and swelling of airways occur. This causes widespread variable airflow obstruction which makes it difficult for an asthma sufferer to breathe.
Asthma is a chronic disorder, primarily characterized by persistent airway inflanlmation. Asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
100021 Asthma is traditionally managed pharmacologically by: (1) long terni control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both of these approaches require repeated and regular use of prescribed drugs, which often present difficulties in patient compliance. I-ligh doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty of avoiding stimulus that triggers asthma is also a common barrier to successful asthma management. As such, current management techniques are neither completely successful nor free from side effects.
100031 Presently, a new treatment for asthma is showing prontise. 'I'his treatment comprises the application of energy to the airway tissue. This treatment is described in more detail in commonly assigned U.S. Patent Nos. 6,411,852;
6,634,363; 7,027,869; 7,104,987 and U.S. Publication No. 2005/0010270, cach of which is incorporated herein by reference.
100041 1'he application of energy to airway tissue, when performed via insertion of a treatment device into the bronchial passageways, requires navigation through tortuous anatomy as well as the ability to treat a variety of sizes of bronchial passageways. As discussed in the above referenced patents and applications, use of a radio frequency (RF) energy delivery device provides one mechanism for treating tissue within the bronchial passageways.
100051 Fig. 1 illustrates a bronchial tree 90. As noted herein, devices treating areas of the lungs desirably have a construction that enables navigation through the tortuous passages. As shown, the various bronchioles 92 decrease in size and have many branching segments 96 as they extend into the right and left bronchi 94.
Accordingly, an efficient treatment utilizes devices that are able to treat airways of varying sizes as well as function properly when repeatedly deployed after navigating through the tortuous anatomy.
100061 In addition to considerations of navigation and site access, there exists the matter of device orientation at the treatment site. The treatment devices generally make contact or are placed in close proximity to the target tissue. I-Iowever, in utilizing the treatment devices in a patient, visibility of the energy delivery element, particularly depth perception, within the lung airways may be relatively limited as viewed from an imaging lens of an access device, such as a bronchoscope or endoscope. Limited visibility combined with a variety of other factors, including airway movement due to patient breathing, coughing, and/or wheezing (tidal motion) as well as movement of the access device, may make it difficult to ensure desired axial treatment of the lung airways with the energy delivery device.
100071 For example, in procedures where a relatively long region of tissue is to be treated (e.g., longer than a length of the energy delivery element), difficulty in ascertaining the amount of tissue being treated may result in over-treatment of the same region or non-treatment of the target region. In particular, as the energy delivery element is translated from a first region to a second region and so on, portions of the target tissue may be over-treated or skipped entirely.
Additionally, such conditions may result in slower procedures that increase total procedure time and patient discomfort.
[0008] In view of the above, methods and devices are desired for treating tortuous anatomy such as the bronchial passages which enable a user to effectively and efficiently treat tissue and relocate an energy delivery device along one or more portions of the tissue.
SUMMARY OF THE INVENTION
100091 In treating tissue regions, such as within the lungs, a treatment device may utilize an elongate sheath or shaft having a plurality of markers, rings, bands, or other visual indicators along an outer surface thereof so as to facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous (adjacent), overlapping, intermittently spaced apart (gapping), or a combination thereof as determined by the marker spacing, and as desired. The visual indicators may also serve as a mechanism for measuring a depth of the treatment device, the tissue length, and/or treatment length, as further described below.
100101 In one aspect of the present invention, an energy delivery device such as an RF electrode basket may be advanced within a working channel of an access device, such as a bronchoscope or endoscope, until a final proximal marker, e.g., a fourth mark, is extended outside the access device, such that the electrode basket, or at least a proximal insulation thereof, and the markers are visible via an imaging lens in the access device. The electrode basket may be deployed into contact against the tissue to be treated and then activated. The treatment device may then be pulled proximally until the next adjacent mark, e.g., a third mark, is reached.
"1'his process of activation and pulling proximally may be repeated until a last mark is reached providing for a contiguous and/or continuous axial treatment length of the tissue.
100111 In another aspect of the present invention, the treatment device which may be used in a body conduit, cavity, passageway, or lumen, such as a lung airway.
may generally comprise an elongate body, an energy delivery element, and one or more visual indicators. The elongate body comprises a proximal portion with a proximal end and a distal portion with a distal end. The energy delivery element may be disposed at the distal end of the elongate body. The one or more visual indicators may be disposed on the distal portion of the elongate body. Significantly, the visual indicators are separated by a predetermined spacing distance so as to provide the desired predetermined axial treatment in the body conduit or cavity.
100121 In yet another aspect of the prevent invention, the treatment device may comprise a radio frequency energy delivery device for use in a lung airway so as to treat asthma. The device comprises an elongate body having a proximal portion with a proximal end and a distal portion with a distal end. A RF electrode is disposed at the distal end of the elongate body. A plurality of visual indicators are disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
100131 In a further aspect of the present invention, one method for using the treatment device to deliver energy may generally comprise positioning the access device having a visualization element within a lung airway so as to access airways that are typically 3 mm (or smaller) to 10 mm (or larger) in diameter, as can be properly viewed with direct real-time visualization. The access device may then be stabilized or anchored. The energy delivery device is advanced within the access device so that at least one visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element. The visual indicators in turn will provide the desired predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
[0014] A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
100151 The following drawings should be read with reference to the detailed description. Like numbers in different drawings refer to like elements. The drawings, which are not necessarily to scale, illustratively depict embodiments of the present invention and are not intended to limit the scope of the invention.
100161 Fig. I is an illustration of the airways within a human lung.
100171 Fig. 2 illustrates a schematic view of a treatment system for delivering energy to tissue utilizing an expandable electrode basket.
100181 Fig. 3A illustrates a side view of the treatment device of Fig. 2 extending distally from a bronchoscope, wherein the device has an active distal end for treating tissue using energy delivery.
100191 Fig. 3B illustrates a variation of a treatment device comprising an expandable body, such as a balloon, having one or more electrodes disposed along its surface.
BACKGROUND OF 'I'1-IE INVENTION
100011 Asthma is a disease in which bronchoconstriction, excessive mucus production, and inflammation and swelling of airways occur. This causes widespread variable airflow obstruction which makes it difficult for an asthma sufferer to breathe.
Asthma is a chronic disorder, primarily characterized by persistent airway inflanlmation. Asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
100021 Asthma is traditionally managed pharmacologically by: (1) long terni control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both of these approaches require repeated and regular use of prescribed drugs, which often present difficulties in patient compliance. I-ligh doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty of avoiding stimulus that triggers asthma is also a common barrier to successful asthma management. As such, current management techniques are neither completely successful nor free from side effects.
100031 Presently, a new treatment for asthma is showing prontise. 'I'his treatment comprises the application of energy to the airway tissue. This treatment is described in more detail in commonly assigned U.S. Patent Nos. 6,411,852;
6,634,363; 7,027,869; 7,104,987 and U.S. Publication No. 2005/0010270, cach of which is incorporated herein by reference.
100041 1'he application of energy to airway tissue, when performed via insertion of a treatment device into the bronchial passageways, requires navigation through tortuous anatomy as well as the ability to treat a variety of sizes of bronchial passageways. As discussed in the above referenced patents and applications, use of a radio frequency (RF) energy delivery device provides one mechanism for treating tissue within the bronchial passageways.
100051 Fig. 1 illustrates a bronchial tree 90. As noted herein, devices treating areas of the lungs desirably have a construction that enables navigation through the tortuous passages. As shown, the various bronchioles 92 decrease in size and have many branching segments 96 as they extend into the right and left bronchi 94.
Accordingly, an efficient treatment utilizes devices that are able to treat airways of varying sizes as well as function properly when repeatedly deployed after navigating through the tortuous anatomy.
100061 In addition to considerations of navigation and site access, there exists the matter of device orientation at the treatment site. The treatment devices generally make contact or are placed in close proximity to the target tissue. I-Iowever, in utilizing the treatment devices in a patient, visibility of the energy delivery element, particularly depth perception, within the lung airways may be relatively limited as viewed from an imaging lens of an access device, such as a bronchoscope or endoscope. Limited visibility combined with a variety of other factors, including airway movement due to patient breathing, coughing, and/or wheezing (tidal motion) as well as movement of the access device, may make it difficult to ensure desired axial treatment of the lung airways with the energy delivery device.
100071 For example, in procedures where a relatively long region of tissue is to be treated (e.g., longer than a length of the energy delivery element), difficulty in ascertaining the amount of tissue being treated may result in over-treatment of the same region or non-treatment of the target region. In particular, as the energy delivery element is translated from a first region to a second region and so on, portions of the target tissue may be over-treated or skipped entirely.
Additionally, such conditions may result in slower procedures that increase total procedure time and patient discomfort.
[0008] In view of the above, methods and devices are desired for treating tortuous anatomy such as the bronchial passages which enable a user to effectively and efficiently treat tissue and relocate an energy delivery device along one or more portions of the tissue.
SUMMARY OF THE INVENTION
100091 In treating tissue regions, such as within the lungs, a treatment device may utilize an elongate sheath or shaft having a plurality of markers, rings, bands, or other visual indicators along an outer surface thereof so as to facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous (adjacent), overlapping, intermittently spaced apart (gapping), or a combination thereof as determined by the marker spacing, and as desired. The visual indicators may also serve as a mechanism for measuring a depth of the treatment device, the tissue length, and/or treatment length, as further described below.
100101 In one aspect of the present invention, an energy delivery device such as an RF electrode basket may be advanced within a working channel of an access device, such as a bronchoscope or endoscope, until a final proximal marker, e.g., a fourth mark, is extended outside the access device, such that the electrode basket, or at least a proximal insulation thereof, and the markers are visible via an imaging lens in the access device. The electrode basket may be deployed into contact against the tissue to be treated and then activated. The treatment device may then be pulled proximally until the next adjacent mark, e.g., a third mark, is reached.
"1'his process of activation and pulling proximally may be repeated until a last mark is reached providing for a contiguous and/or continuous axial treatment length of the tissue.
100111 In another aspect of the present invention, the treatment device which may be used in a body conduit, cavity, passageway, or lumen, such as a lung airway.
may generally comprise an elongate body, an energy delivery element, and one or more visual indicators. The elongate body comprises a proximal portion with a proximal end and a distal portion with a distal end. The energy delivery element may be disposed at the distal end of the elongate body. The one or more visual indicators may be disposed on the distal portion of the elongate body. Significantly, the visual indicators are separated by a predetermined spacing distance so as to provide the desired predetermined axial treatment in the body conduit or cavity.
100121 In yet another aspect of the prevent invention, the treatment device may comprise a radio frequency energy delivery device for use in a lung airway so as to treat asthma. The device comprises an elongate body having a proximal portion with a proximal end and a distal portion with a distal end. A RF electrode is disposed at the distal end of the elongate body. A plurality of visual indicators are disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
100131 In a further aspect of the present invention, one method for using the treatment device to deliver energy may generally comprise positioning the access device having a visualization element within a lung airway so as to access airways that are typically 3 mm (or smaller) to 10 mm (or larger) in diameter, as can be properly viewed with direct real-time visualization. The access device may then be stabilized or anchored. The energy delivery device is advanced within the access device so that at least one visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element. The visual indicators in turn will provide the desired predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
[0014] A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
100151 The following drawings should be read with reference to the detailed description. Like numbers in different drawings refer to like elements. The drawings, which are not necessarily to scale, illustratively depict embodiments of the present invention and are not intended to limit the scope of the invention.
100161 Fig. I is an illustration of the airways within a human lung.
100171 Fig. 2 illustrates a schematic view of a treatment system for delivering energy to tissue utilizing an expandable electrode basket.
100181 Fig. 3A illustrates a side view of the treatment device of Fig. 2 extending distally from a bronchoscope, wherein the device has an active distal end for treating tissue using energy delivery.
100191 Fig. 3B illustrates a variation of a treatment device comprising an expandable body, such as a balloon, having one or more electrodes disposed along its surface.
100201 Fig. 4 illustrates an exemplary schematic view of an expandable electrode basket projecting distally from an elongate sheath having one or more markers delineated along its length and a representative image on a monitor corresponding to an image as viewed from the bronchoscope, wherein the spacing distance between each adjacent marker corresponds to a length of the electrodes located on the treatment device.
[00211 Fig. 5 illustrates the energy delivery device of Fig. 4 advanced into a bronchial airway and positioned for treatment upon the tissue.
100221 Figs. 6A and 6B illustrates the treatment device advanced distally within an airway lumen for treating the tissue and the corresponding image from a bronchoscope on a monitor showing the markers along the sheath.
100231 Figs. 7A and 7B illustrate the treatment device pulled proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to an adjacent region of tissue to be treated.
100241 Figs. 8A and 8B illustrate the treatment device pulled further proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to another adjacent region of tissue to be treated.
100251 Fig. 9A illustrates a variation of the sheath utilizing dashed markers.
100261 Fig. 9B illustrates another variation of the sheath utilizing non-uniform markers.
100271 Fig. 9C illustrates another variation of the sheath utilizing markers which have a length between adjacent markers which is less than a length of the electrodes on the treatment device such that overlapping regions of tissue may be treated.
100281 Fig. 9D illustrates yet another variation of the sheath utilizing markers having graduated measurements therealong to provide a visual indication of tissue or treatment length and/or electrode basket depth.
100291 Fig. 9E illustrates yet another variation of the sheath utilizing markers having alternative colors, such as a green marker to indicate treatment device deployment or a red marker to indicate a maximum length of sheath extension.
100301 Fig. 9F illustrates still another variation of the sheath utilizing markers which have a length between adjacent markers which is greater than a length of the electrodes on the treatment device such that intermittent regions of tissue may be treated.
DETAILED DESCRIPTION OF THE INVENTION
100311 It will be appreciated that the examples below discuss uses in the airways of the lungs. However, unless specifically noted, the devices and methods described herein are not limited to use in the bronchial passageways. Instead, such devices and methods may have applicability in various parts of the body, such as the upper respiratory tract, trachea, esophagus, urethra, ureter, digestive tract, cardiovascular system, circulatory system, arthroscopic, brain, liver, etc.
Moreover, the present invention may be used in various procedures where the benefits of the device are desired.
100321 Generally, in treating tissue regions within the lungs, the treatment device may utilize an elongate body, such as tubular sheath, shaft, or catheter, having a plurality of markers, rings, bands, or other visual indicators (e.g., circular or otherwise) along an outer surface thereof. The plurality of visual indicators facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous, overlapping, or intermittently spaced apart treatment of the lung airway walls with the energy delivery element(s). The plurality of visual indicators may also serve as a mechanism to measure a depth of the device, tissue length, airway segment length, and/or treatment length.
100331 In one example of operation, the treatment device, such as an RF
electrode basket assembly, may be advanced within a working channel of an access device, such as a bronchoscope, until a final proximal marker is extended distally from the access device while under direct real-time visualization. With the treatment device and the markers visible through the access device, the electrode basket assembly may be deployed against the tissue to be treated and activated. The treatment device may then be pulled proximally relative to the access device until the next adjacent marker is reached. The treatment device may then be activated to treat the portion of tissue adjacent to the previously treated portion without overlap (i.e., over-treatment of the same region) or separation (i.e., non-treatment of target tissue) between the adjacent portions of treated tissue. This process of activation and pulling proximally may be repeated until the last mark is reached providing for a continuous axial treatment where the target tissue regions are neither over-treated nor skipped.
100341 Referring now to Fig. 2, a schematic diagram of one example of a treatment system 10 for delivering therapeutic energy to tissue of a patient is illustrated. The system 10 comprises a power supply having an energy generator 12, a controller 14 coupled to the energy generator 12, and a user interface surface 16 in communication with the controller 14. The system 10 further includes an energy delivery device 20, a return electrode 40 (if the system 10 employs a mono-polar RF
configuration), and foot actuation pedal(s) 42. It will be appreciated that the above depictions are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of the system 10 or device 20. This applies to all depictions hereinafter.
10035] The system 10 depicted in Fig. 2 shows the user interface portion 16 having one or more connections 36, 44, 46 for the device 20, the return clectrode 40 (optional), and the actuation pedal(s) 42 (optional) respectively. The user interface 16 may also include visual prompts 48, 50, 52, 54 for user feedback regarding setup or operation of the system 10. The user interface 16 may also employ graphical representations of components of the system 10, audio tone generators, as well as other features to assist the user with system operation.
100361 The controller 14 may be configured to deliver RF energy in either a mono-polar or bi-polar configuration. In many variations of the system 10, the controller 14 may include a processor 38 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling the energy generator 12. The processor 38 may also accept information from the system 10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system. The processor 38 of the controller 14 may be a digital IC processor, analog processor, or any other suitable logic or control system that carries out the control algorithms.
100371 Detailed descriptions on the processor 38, user interface 16, and safety algoritlims that are useful for the treatment of asthma as discussed above may be found in commonly assigned U.S. Patent Application No. 11/408,688, filed April 21, 2006, entitled CONTROL METHODS AND DEVICES FOR ENERGY DELIVERY, which is incorporated herein by reference.
100381 It is understood that the device 20 of the present invention may be used with a variety of systems 10, having the same or different components as described in Fig. 2. For example, although the device 20 is described with reference to RF
energy delivery systems 10, variations of the device and system may include light energy sources, laser systems, resistive heating systems, infrared heating elements, microwave energy systems, focused ultrasound, cryo-ablation, radiation, electrical stimulation, or any other energy delivery system or configuration.
100391 "I'he energy delivery device 20 may include a flexible tubular sheath 22, an elongate shaft 24 (in this example, the shaft 24 extends out from the distal end of the sheath 22), and a handle or other optional operator interface 26 secured to a proximal end of the sheath 22. The distal portion of the device 20 includes an energy transfer element 28 for applying energy to the tissue of interest. The energy transfer element 28, such as an expandable electrode basket, may be advanced into and through the patient body in an atraumatic low profile configuration. Upon reaching the designed tissue region to be treated, the energy transfer element 28 may be expanded or reconfigured into a treatment configuration which facilitates contact of the element 28 against the tissue to be treated. In one example, the energy transfer element 28 may be reconfigured via a pull wire 21 routed proximally through elongate shaft 24 and/or flexible sheath 22 and affixed to a handle 26 and actuated with a slide mechanism 34.
100401 Additionally, the device 20 may includes a connector 30 common to such energy delivery devices. The connector 30 may be integral to the end of a cable 32 coupled to the handle 26 or the connector 30 may be fitted to receive a separate cable 32. In any case, the device 20 is configured for attachment to the power supply via some type of connector or adaptor plug 30. The elongate shaft 24 and/or flexible sheath 22 may also be configured and sized to permit passage through a working channel of a commercially available bronchoscope or endoscope. However, the device 20 may also be advanced into a body conduit or cavity with or without a steerable catheter, in a minimally invasive procedure, in an open surgical procedure, or with or without the guidance of various vision or imaging systems.
100411 T'he devices 20 of the present invention will have a sufficient length and/or diameter and/or flexibility to access the tissue targeted for treatment. For example, treating airways as small as 3 mm in diameter may utilize the flexible sheath 22 and/or elongate shaft 24 which is sufficiently long and sized in diameter to reach deep into the lungs to treat the airways. Generally the device shaft 24 and/or sheath 22 will have a length in range from about 0.5 feet to about 8.0 feet and an expanded basket diameter 28 in a range from about 1 mm to about 25 mm, more preferably from about 3 mm to about 10 mm. However, it is noted that this example is merely illustrative and is not limiting in dimension or flexibility.
100421 Referring now to Fig. 3A, an example of an energy transfer device 28 is illustrated as an expandable electrode basket. The device 28 has one or more legs 60 configured in the form of a basket 62 converging to an atraumatic common distal tip 68. The basket 62 may reconfigure from an atraumatic low profile shape to an expanded or deployed configuration to facilitate contact against the tissue walls of a body conduit, cavity, passageway, or lumen, such as a lung airway wall.
Examples of such devices are described in greater detail in commonly assigned U.S.
Publication No. 2003/0233099, which is incorporated herein by reference.
100431 The one or more legs 60 may be configured into the basket shape 62 such that the legs 60 may expand radially during operation to a working diameter as described above that will achieve contact between the legs 60 having active elcetrode regions 64 and the airway walls. The legs 60 may also include temperature sensors for tissue temperature feedback to the controller 14. In this configuration, four legs 60 are shown, however any number of legs 60 may be utilized to form the basket (e.g.. 2. 3. 4. 5, 6, 7, 8, 9, 10, etc.).
100441 As illustrated in Fig. 3A, a pull wire 66 may extend through a lumen of the elongate shaft body 24, to which the basket 62 may be directly mounted.
I'ull wire 66 may be utilized to deliver energy to the active electrodes 64 and/or assist basket 62 in expanding into its deployed treatment configuration. The treatnient device 62 may optionally be delivered to a treatment site directly through the elongate delivery sheath or sleeve body 22. In still other embodiments, pull wire 66 may be omitted entirely in which case basket 62 niay be expanded or deployed by utilizing one or more legs 60 which are fabricated as elastic, super-elastic, or shape memory alloys (e.g., nickel-titanium alloys) which may self-expand from a compressed configuration when removed from the elongate sheath 22. In sunimary, basket 62 may expand upon activation by the user or it may automatically expand when advanced out of a restraining sheath 22 or when the sheath 22 is withdrawn proxi-nally from the basket 62.
100451 The energy transfer device 28 is shown in association with a bronchoscope access device 70. The elongate shaft 24 and flexible sheath 22 are received within a working channel 72 of the bronchoscope 70. Accordingly, the energy transfer device 28 may be utilized along with an imaging lumen 76 and/or ligllt optical fibers 74 of the bronchoscope 70. The imaging lumen 76 may utilize visualization elements, such as CCD imaging or a camera lens. "I'he bronchoscope 70 may additionally comprise an aspiration lumen (not shown).
100461 Referring now to Fig. 3B, an alternative configuration of the energy transfer device 80 is illustrated. The active member 80 is configured as a body 82 having a set diameter and length. One or more electrodes 84 are shown secured to the body 82 tlirough holes 86 or adhesives or other attachment mechanisms. The electrodes 84 inay be oriented axially relative to the body 82 to optimize contact along the tissue walls during treatment. The diameter of active member 80 is set to correspond to that desired for treating a given body lumen or passageway, such as lung airway. Accordingly, body 82 may be configured as an inflatable balloon member. an expandable scaffold member, and the like, where the elcctrodes 84 will move outward upon body 82 expansion.
100471 Energy delivery devices 28, 80 of wire frames and/or basket configurations will generally have its members (e.g., electrodes) symmetrically deployed. "1'his shape may be round, rounded, or polygonal in cross section.
'I'hese and other configurations, including asymmetrical active member configurations, are describcd in detail in U.S. Patent Application Nos. 11/255,796, filed October 21, 2005. entitled IMPROVED ENERGY DELIVERY DEVICES AND METI-IODS and 11/420,438, filed May 25, 2006, entitled MEDICAL DEVICE WI'1'1-I PROCEDURE
IMPROVEMENT FEATURES, each of which is incorporated herein by reference.
100481 Referring now to Fig. 4, one variation of an exemplary treatment device is shown which facilitates guidance of the expandable electrode basket 62 so as to effectively and efficiently treat tissue as desired, particularly relatively long portions of tissue (e.g., regions of tissue longer than a length of the electrode 64). In this embodiment, the basket 62 is disposed at the distal end of the elongate sheath 22 which in turn is shown projecting distally outward from the bronchoscope 70.
One or more visual indicators 100 are disposed along a length of the elongate sheath 22 (or shaft 24), pref'erably on a distal portion of the sheath 22 and proximal to the basket 62.
Visual indicators 100 may generally comprise one or more markers, rings, bands, and the like. For example, a first marker 102 may be positioned proximally oi' basket 62, a second marker 104 niay be positioned proximally of first marker 102, a third marker 106 may be positioned proxintally of second marker 104, and a fourth marker niay be positioned proximally of third marker 106. In another variation, at least two circular bands or rings ntay be utilized and in other variations, four circular bands or rings may be utilized. It will be appreciated that any number, type, and/or combination of markers, rings or bands may be utilized in the present invention (e.g., 2. 3, 4, 5, 6. 7. 8, 9, 10, etc.).
100491 Each marker 102, 104, 106, 108 may be uniformly spaced apart from one another with each spacing matching the length of the active electrodes 64 of' basket 62. Thus, each spacing between markers 102, 104, 106, 108 may be set to correspond to a length of'a active electrode 64 located centrally between proximal and distal insulation regions 61, 63 of the basket leg 60. For instance, active electrodes 64 having a length of 5 mm along basket 62 may provide for a length of 5 mm between markers 102, 104, 106, 108. It will be appreciated that the active electrode length 64 and corresponding marker spacing of 5 mm is illustrative and other lcngths fewer than 5 mm or greater than 5 mm may also be utilized as desired. For example, the predetermined spacing distance may range anywhere from about 3 mm to about 30 mni, more preferably in a range from about 5 mm to about 15 mm, depending on the active electrode length, basket leg length, electrode array length parallel to a longitudinal axis of the airway lumen, treatment temperature, time, power, current, voltage, and/or energy settings, and/or polarity configuration.
100501 As mentioned above, in one variation the spacing between these markers 102, 104, 106, 108 may each correspond to a length LE of the active electrodes 64 on basket 62. For instance, a first marker distance LSI between first niarker 102 and second marker 104, a second marker distance LS2 between second niarker 104 and third marker 106, and a third marker distance LS3 between third niarker 106 and fourth marker 108 may each correspond in length to the length LE of active electrodes 64 on basket 62. Moreover, although four markers are illustrated in this example, fewer than four or more than four markers, as desired, niay be utilized along the length of elongate sheath 22 in alternative variations.
100511 Bronchoscope 70 may be electrically coupled 110 to a monitor 112 and/or processor configured to display images 114 received from imaging lumen 76.
As represented on monitor 112, the displayed image corresponds to an image as viewed from the perspective of lumen 76 showing basket 62 projected from the elongate sheath 22. Also illustrated are the visual markings 100 positioned along the sheath 22.
100521 Advantageously, the embodiment of Fig. 4 allows for the amount of tissue being treated by the basket 62 to be easily ascertained with reference to the visual markers 100. In particular, markers 100 improve visibility and/or navigation of locating and placing the treatment electrodes 64 so as to reliably and uniformly apply predetermined axial treatments (e.g., continuous activation treatnients). This in turn niay reduce physician effort or fatigue (e.g., less surgical technique sensitive), total treatnient procedure time, and/or patient discomfort and improve procedure etTicacy.
100531 Referring now to Figs. 5 through 8B, the basket 62 and elongate sheath 22 may be deployed from bronchoscope 70 and positioned distally of bronchoscope 70 along the tissue wall of a bifurcated airway 96. In one example of use, basket 62 may be deployed from bronchoscope 70 and advanced distally relative to bronchoscope working channel 72, as shown in Fig. 6A, while visualizing the passage of markers 102, 104, 106, 108 in monitor 112 directly in real-time, as illustrated in Fig. 613. With basket 62 positioned, it niay be expanded into contact against the surrounding tissue wall 96 and the active electrodes 64 may be activated to heat the airway tissue 120 along a treatment length LE3. The treated tissue length LE3, extending between tissue borders 122, 124, may correspond in length to third marker spacing distance LS3 on elongate sheath 22.
[00541 Once the treatment is completed along tissue length LE3, basket 62 may be retracted and withdrawn proximally relative to bronchoscope 70 whilc visualizing on monitor 112 by one marker length until the fourth marker 108 is no longer visible and third marker 106 is verified as visible in the nlonitor 112, as shown in Fig. 7B. Moving elongate sheath 22 by such a distance also translates basket 62 proximally by one niarker length LS3 and correspondingly translates the active electrodes 64 to an adjacent tissue region proximal to the previously treated tissue length LE3. Once desirably positioned, basket 62 may then again be actuated so as to deploy against the airway wall 96 and activated to heat the airway tissue 121 along a trcatnlent length LE2 which borders treated tissue length LE3 contiguously without overlapping or leaving any gap between the two treated tissue lengths, as shown in Fig. 7A.
100551 Once the tissue along tissue length LE2 has been treated, basket 62 may once again be retracted and withdrawn proximally relative to bronchoscope by another marker length such that third marker 106 is no longer visible and second marker 104 is verified as visible on the monitor 112, as shown in Fig. 8B.
Accordingly, basket 62 is translated proximally by a corresponding distance along the tissue such that the active electrodes 64 are aligned between tissue borders 126 and 128. The basket 62 niay then be activated to treat the tissue region 123 along tissue length LE1 wllich borders treated tissue length LE2, as illustrated in Fig.
8A. 'I'his process of deploying, activating, retracting, and pulling proximally may be repeated, as desired, until first marker 102 is reached or by pulling the bronchoscope proximally with respect to the sheath markers 100 and following the above steps relative to the stationary bronchoscope 70. 'I'hus, longer portions of the tissue may be treated as desired.
100561 The resulting treated tissue may be thus formed into a contiguous length of treated tissue (e.g., LEI, LE2, LE3) which avoids over-treating the tissue by avoiding overlapping regions and avoids the formation of gaps between adjacent tissue lengths. Once the treatment is completed, the basket 62 may be withdrawn proximally into the bronchoscope working channel 72 for withdrawal from the patient or advancement into another region of tissue to be treated. Thus, if the length of the active electrode 64 is 5 mm and the corresponding marker lengths LSI. LS2. LS3 are each 5 mm in length, the tissue may be treated in increments of 5, 10, 15, 20 mm or niore in a contiguous manner depending upon the desired length of tissue to be treated. The predetermined axial treatment (e.g.. LE1, LE2, LE3) may comprise treatment of the lung airways for a length of at least 10 mm, preferably in a range t'rom about 10 nint to about 75 mm, more preferably in a range from about 20 mm to about 30 mm.
100571 It will be appreciated that there are several ways to use the device of the present invention, and as such is not limited by the above example. In an alternative rnethod of use, elongate sheath 22 may be translated distally relative to bronchoscope 70 such that the initial treatment is initiated when first marker 102 is visualized. Accordingly, subsequent portions of tissue may be treated by advancing the basket 62 distally relative to bronchoscope 70 while viewing advancement of the markers on monitor 112. In yet another variation, the elongate sheath 22 and basket 62 may be initially advanced distally until the first marker 102, second marker 104. or third marker 106 is exposed rather than being fully advanced until the fourth marker 108 is exposed. Thus, shorter portions of the tissue may be treated as desired.
100581 Referring now to Figs. 9A through 9F, although markers 100 may be identical, it will be appreciated that they may also be varied in any number of configurations. For example, Fig. 9A illustrates one variation where the markers 130.
132, 134, 136 may be dashed rather than solid. Another variation is shown in Fig. 9B
where the markers may be non-uniform in width, or alternating in width. For instance, inarkers 140. 144 may have a first width while alternating markers 142. 146 may have a second width larger than the first width.
100591 In yet another variation, the markers 150, 152, 154, 156 may be aligned to correspond to the active electrode length, as described above.
Additional half markers 158, 160. 162 may be marked at, e.g., intermediate positions between markers 150. 152, 154, 156, to denote positions where portions of tissue may be treated by overlapping the treatment regions, as shown in Fig. 9C.
100601 Another variation is illustrated in Fig. 9D where markers 170. 172.
174, 176 may be graduated with length measurements, e.g., 5 mm, 10 mm, 15 mm, mm. etc., niuch like an endoscope to facilitate measurement of basket 62 insertion depth or to facilitate measurement of the tissue region (e.g., length of the lung airway). In this manner, a portion of tissue or the depth in which the treatment dcvice is advanced may be ascertained by directly visualizing the elongate sheath 22 extending from the stationary bronchoscope 70. Although the measurenient values are illustrated in 5 mm increments corresponding to the length of the active electrode 64 on the electrode basket 62, any number of incremental values may be marked and delineated either in a corresponding or even non-corresponding manner with respect to the active electrodes, if so desired.
100611 Referring now to Fig. 9E, an elongate sheath 22 having markers whiclt are in various colors to denote particular features associated with that particular marking is illustrated. Although the markers may be colored in the same color (e.g..
black), various colors niay be utilized, particularly to indicate predetermined device states. For example, marker 180 may comprise a first color (e.g., green) to indicate that once niarker 180 is visible, electrode basket 62 is sufficiently advanced relative to the bronchoscope 70 for expansion and/or activation. Additional markers 182, niay also conlprise various colors as well while the proximal marker 186 may also be colored in yet another color (e.g., red) as a visual indication that the elongate sheath 22 should not be advanced any further distal into the airway lung.
100621 In yet another variation, markers 171, 173, 175 (witli graduations 7 mm, 14 mm, 21 mm) may have a length between adjacent markers which is greater than a length of the active electrodes 64 of the treatment device so that intennittent regions ol'tissue may be treated, as shown in Fig. 9F. Still further, the sheath may have a second set of markers 177, 179, 181, 183 that have a different spacing distance. e.g., set to the active electrode 64 length, so that a user may utilize a particular marker set based on a particular anatomy section to be treated.
10063] In these and other variations described herein, each of the markers may be marked on the elongate sheath 22 in various increments and are not limited to just the length of the active electrodes 64, as described above in detail.
Moreover, additional markers may be utilized or as few as a single marker may be utilized depending upon the desired visual indications.
100641 The markers may also serve as a safety feature to discourage the pre-mature deployment of the electrode basket 62 within the bronchoscope 70. For example, the first proximal marker may serve this purpose so as to prevent against any electrical discharge from flowing proximally along the sheath 22, shaft 24 and/or bronchoscope 70, which could potentially result in injury or harm to the patient or user. Additionally, the final proximal marker, which may be positioned along sheath 22 up to 75 mm or more, more preferably up to 50 mm or 30 mm, from the electrode basket 62, may also serve as a visual safety feature to ensure against advancing the electrode basket 62 too deep into the patient body (i.e., beyond bronchoscopic vision), which in turn prevents against any patient harm, such as puncturing of the airway wall into the parenchyma, pneumothorax, pneumomediastinum, etc.
100651 In yet another alternative, at least one of the markers may also be aligned %vith an anatomical landmark within the lung airway to provide not only for alignment of the device but also to facilitate measurement of the lung airway, if so desired. For example, a marker may be aligned with a particular airway bifurcation, colored tissue, cartilage ring, tissue nodule, and the like, so as to ensure against user disorientation due to tidal motion or movement of the access device.
100661 Referring back to Fig. 8B, it will be further appreciated that the markers 102 further allow for user differentiation of the sheath 22 from the insulated electrodes 61, 63, particularly the proximal insulation regions of the basket legs 60.
This visualization is important to ensure proper deployment of the basket electrode 62.
100671 Although certain exemplary embodiments and methods have been dcscribed in some detail, for clarity of understanding and by way of example, it will be apparent from the foregoing disclosure to those skilled in the art that variations, modifications, changes, and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention. For example, the plurality of visual indicators may be located on the device shaft, the energy delivery device may comprise a non-RF source, and/or the expandable energy device may comprise an inflatable balloon member. Still further, the markers of the present invention may be positioned alternatively or additionally on a proximal portion of the sheath or shaft that extends at least partially outside the access device and patient.
Proximal makers may also facilitate quicker and more confident introduction of the shaft into the access device by indicating a measurement of the shaft within the access device. Reference to a singular element, includes the possibility that there are plural of the same elements present. More specifically, as used herein and in the appended claims, the singular forms "a," "an," "said," and "the" include plural referents unless the context clearly dictates otherwise. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
[00211 Fig. 5 illustrates the energy delivery device of Fig. 4 advanced into a bronchial airway and positioned for treatment upon the tissue.
100221 Figs. 6A and 6B illustrates the treatment device advanced distally within an airway lumen for treating the tissue and the corresponding image from a bronchoscope on a monitor showing the markers along the sheath.
100231 Figs. 7A and 7B illustrate the treatment device pulled proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to an adjacent region of tissue to be treated.
100241 Figs. 8A and 8B illustrate the treatment device pulled further proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to another adjacent region of tissue to be treated.
100251 Fig. 9A illustrates a variation of the sheath utilizing dashed markers.
100261 Fig. 9B illustrates another variation of the sheath utilizing non-uniform markers.
100271 Fig. 9C illustrates another variation of the sheath utilizing markers which have a length between adjacent markers which is less than a length of the electrodes on the treatment device such that overlapping regions of tissue may be treated.
100281 Fig. 9D illustrates yet another variation of the sheath utilizing markers having graduated measurements therealong to provide a visual indication of tissue or treatment length and/or electrode basket depth.
100291 Fig. 9E illustrates yet another variation of the sheath utilizing markers having alternative colors, such as a green marker to indicate treatment device deployment or a red marker to indicate a maximum length of sheath extension.
100301 Fig. 9F illustrates still another variation of the sheath utilizing markers which have a length between adjacent markers which is greater than a length of the electrodes on the treatment device such that intermittent regions of tissue may be treated.
DETAILED DESCRIPTION OF THE INVENTION
100311 It will be appreciated that the examples below discuss uses in the airways of the lungs. However, unless specifically noted, the devices and methods described herein are not limited to use in the bronchial passageways. Instead, such devices and methods may have applicability in various parts of the body, such as the upper respiratory tract, trachea, esophagus, urethra, ureter, digestive tract, cardiovascular system, circulatory system, arthroscopic, brain, liver, etc.
Moreover, the present invention may be used in various procedures where the benefits of the device are desired.
100321 Generally, in treating tissue regions within the lungs, the treatment device may utilize an elongate body, such as tubular sheath, shaft, or catheter, having a plurality of markers, rings, bands, or other visual indicators (e.g., circular or otherwise) along an outer surface thereof. The plurality of visual indicators facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous, overlapping, or intermittently spaced apart treatment of the lung airway walls with the energy delivery element(s). The plurality of visual indicators may also serve as a mechanism to measure a depth of the device, tissue length, airway segment length, and/or treatment length.
100331 In one example of operation, the treatment device, such as an RF
electrode basket assembly, may be advanced within a working channel of an access device, such as a bronchoscope, until a final proximal marker is extended distally from the access device while under direct real-time visualization. With the treatment device and the markers visible through the access device, the electrode basket assembly may be deployed against the tissue to be treated and activated. The treatment device may then be pulled proximally relative to the access device until the next adjacent marker is reached. The treatment device may then be activated to treat the portion of tissue adjacent to the previously treated portion without overlap (i.e., over-treatment of the same region) or separation (i.e., non-treatment of target tissue) between the adjacent portions of treated tissue. This process of activation and pulling proximally may be repeated until the last mark is reached providing for a continuous axial treatment where the target tissue regions are neither over-treated nor skipped.
100341 Referring now to Fig. 2, a schematic diagram of one example of a treatment system 10 for delivering therapeutic energy to tissue of a patient is illustrated. The system 10 comprises a power supply having an energy generator 12, a controller 14 coupled to the energy generator 12, and a user interface surface 16 in communication with the controller 14. The system 10 further includes an energy delivery device 20, a return electrode 40 (if the system 10 employs a mono-polar RF
configuration), and foot actuation pedal(s) 42. It will be appreciated that the above depictions are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of the system 10 or device 20. This applies to all depictions hereinafter.
10035] The system 10 depicted in Fig. 2 shows the user interface portion 16 having one or more connections 36, 44, 46 for the device 20, the return clectrode 40 (optional), and the actuation pedal(s) 42 (optional) respectively. The user interface 16 may also include visual prompts 48, 50, 52, 54 for user feedback regarding setup or operation of the system 10. The user interface 16 may also employ graphical representations of components of the system 10, audio tone generators, as well as other features to assist the user with system operation.
100361 The controller 14 may be configured to deliver RF energy in either a mono-polar or bi-polar configuration. In many variations of the system 10, the controller 14 may include a processor 38 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling the energy generator 12. The processor 38 may also accept information from the system 10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system. The processor 38 of the controller 14 may be a digital IC processor, analog processor, or any other suitable logic or control system that carries out the control algorithms.
100371 Detailed descriptions on the processor 38, user interface 16, and safety algoritlims that are useful for the treatment of asthma as discussed above may be found in commonly assigned U.S. Patent Application No. 11/408,688, filed April 21, 2006, entitled CONTROL METHODS AND DEVICES FOR ENERGY DELIVERY, which is incorporated herein by reference.
100381 It is understood that the device 20 of the present invention may be used with a variety of systems 10, having the same or different components as described in Fig. 2. For example, although the device 20 is described with reference to RF
energy delivery systems 10, variations of the device and system may include light energy sources, laser systems, resistive heating systems, infrared heating elements, microwave energy systems, focused ultrasound, cryo-ablation, radiation, electrical stimulation, or any other energy delivery system or configuration.
100391 "I'he energy delivery device 20 may include a flexible tubular sheath 22, an elongate shaft 24 (in this example, the shaft 24 extends out from the distal end of the sheath 22), and a handle or other optional operator interface 26 secured to a proximal end of the sheath 22. The distal portion of the device 20 includes an energy transfer element 28 for applying energy to the tissue of interest. The energy transfer element 28, such as an expandable electrode basket, may be advanced into and through the patient body in an atraumatic low profile configuration. Upon reaching the designed tissue region to be treated, the energy transfer element 28 may be expanded or reconfigured into a treatment configuration which facilitates contact of the element 28 against the tissue to be treated. In one example, the energy transfer element 28 may be reconfigured via a pull wire 21 routed proximally through elongate shaft 24 and/or flexible sheath 22 and affixed to a handle 26 and actuated with a slide mechanism 34.
100401 Additionally, the device 20 may includes a connector 30 common to such energy delivery devices. The connector 30 may be integral to the end of a cable 32 coupled to the handle 26 or the connector 30 may be fitted to receive a separate cable 32. In any case, the device 20 is configured for attachment to the power supply via some type of connector or adaptor plug 30. The elongate shaft 24 and/or flexible sheath 22 may also be configured and sized to permit passage through a working channel of a commercially available bronchoscope or endoscope. However, the device 20 may also be advanced into a body conduit or cavity with or without a steerable catheter, in a minimally invasive procedure, in an open surgical procedure, or with or without the guidance of various vision or imaging systems.
100411 T'he devices 20 of the present invention will have a sufficient length and/or diameter and/or flexibility to access the tissue targeted for treatment. For example, treating airways as small as 3 mm in diameter may utilize the flexible sheath 22 and/or elongate shaft 24 which is sufficiently long and sized in diameter to reach deep into the lungs to treat the airways. Generally the device shaft 24 and/or sheath 22 will have a length in range from about 0.5 feet to about 8.0 feet and an expanded basket diameter 28 in a range from about 1 mm to about 25 mm, more preferably from about 3 mm to about 10 mm. However, it is noted that this example is merely illustrative and is not limiting in dimension or flexibility.
100421 Referring now to Fig. 3A, an example of an energy transfer device 28 is illustrated as an expandable electrode basket. The device 28 has one or more legs 60 configured in the form of a basket 62 converging to an atraumatic common distal tip 68. The basket 62 may reconfigure from an atraumatic low profile shape to an expanded or deployed configuration to facilitate contact against the tissue walls of a body conduit, cavity, passageway, or lumen, such as a lung airway wall.
Examples of such devices are described in greater detail in commonly assigned U.S.
Publication No. 2003/0233099, which is incorporated herein by reference.
100431 The one or more legs 60 may be configured into the basket shape 62 such that the legs 60 may expand radially during operation to a working diameter as described above that will achieve contact between the legs 60 having active elcetrode regions 64 and the airway walls. The legs 60 may also include temperature sensors for tissue temperature feedback to the controller 14. In this configuration, four legs 60 are shown, however any number of legs 60 may be utilized to form the basket (e.g.. 2. 3. 4. 5, 6, 7, 8, 9, 10, etc.).
100441 As illustrated in Fig. 3A, a pull wire 66 may extend through a lumen of the elongate shaft body 24, to which the basket 62 may be directly mounted.
I'ull wire 66 may be utilized to deliver energy to the active electrodes 64 and/or assist basket 62 in expanding into its deployed treatment configuration. The treatnient device 62 may optionally be delivered to a treatment site directly through the elongate delivery sheath or sleeve body 22. In still other embodiments, pull wire 66 may be omitted entirely in which case basket 62 niay be expanded or deployed by utilizing one or more legs 60 which are fabricated as elastic, super-elastic, or shape memory alloys (e.g., nickel-titanium alloys) which may self-expand from a compressed configuration when removed from the elongate sheath 22. In sunimary, basket 62 may expand upon activation by the user or it may automatically expand when advanced out of a restraining sheath 22 or when the sheath 22 is withdrawn proxi-nally from the basket 62.
100451 The energy transfer device 28 is shown in association with a bronchoscope access device 70. The elongate shaft 24 and flexible sheath 22 are received within a working channel 72 of the bronchoscope 70. Accordingly, the energy transfer device 28 may be utilized along with an imaging lumen 76 and/or ligllt optical fibers 74 of the bronchoscope 70. The imaging lumen 76 may utilize visualization elements, such as CCD imaging or a camera lens. "I'he bronchoscope 70 may additionally comprise an aspiration lumen (not shown).
100461 Referring now to Fig. 3B, an alternative configuration of the energy transfer device 80 is illustrated. The active member 80 is configured as a body 82 having a set diameter and length. One or more electrodes 84 are shown secured to the body 82 tlirough holes 86 or adhesives or other attachment mechanisms. The electrodes 84 inay be oriented axially relative to the body 82 to optimize contact along the tissue walls during treatment. The diameter of active member 80 is set to correspond to that desired for treating a given body lumen or passageway, such as lung airway. Accordingly, body 82 may be configured as an inflatable balloon member. an expandable scaffold member, and the like, where the elcctrodes 84 will move outward upon body 82 expansion.
100471 Energy delivery devices 28, 80 of wire frames and/or basket configurations will generally have its members (e.g., electrodes) symmetrically deployed. "1'his shape may be round, rounded, or polygonal in cross section.
'I'hese and other configurations, including asymmetrical active member configurations, are describcd in detail in U.S. Patent Application Nos. 11/255,796, filed October 21, 2005. entitled IMPROVED ENERGY DELIVERY DEVICES AND METI-IODS and 11/420,438, filed May 25, 2006, entitled MEDICAL DEVICE WI'1'1-I PROCEDURE
IMPROVEMENT FEATURES, each of which is incorporated herein by reference.
100481 Referring now to Fig. 4, one variation of an exemplary treatment device is shown which facilitates guidance of the expandable electrode basket 62 so as to effectively and efficiently treat tissue as desired, particularly relatively long portions of tissue (e.g., regions of tissue longer than a length of the electrode 64). In this embodiment, the basket 62 is disposed at the distal end of the elongate sheath 22 which in turn is shown projecting distally outward from the bronchoscope 70.
One or more visual indicators 100 are disposed along a length of the elongate sheath 22 (or shaft 24), pref'erably on a distal portion of the sheath 22 and proximal to the basket 62.
Visual indicators 100 may generally comprise one or more markers, rings, bands, and the like. For example, a first marker 102 may be positioned proximally oi' basket 62, a second marker 104 niay be positioned proximally of first marker 102, a third marker 106 may be positioned proxintally of second marker 104, and a fourth marker niay be positioned proximally of third marker 106. In another variation, at least two circular bands or rings ntay be utilized and in other variations, four circular bands or rings may be utilized. It will be appreciated that any number, type, and/or combination of markers, rings or bands may be utilized in the present invention (e.g., 2. 3, 4, 5, 6. 7. 8, 9, 10, etc.).
100491 Each marker 102, 104, 106, 108 may be uniformly spaced apart from one another with each spacing matching the length of the active electrodes 64 of' basket 62. Thus, each spacing between markers 102, 104, 106, 108 may be set to correspond to a length of'a active electrode 64 located centrally between proximal and distal insulation regions 61, 63 of the basket leg 60. For instance, active electrodes 64 having a length of 5 mm along basket 62 may provide for a length of 5 mm between markers 102, 104, 106, 108. It will be appreciated that the active electrode length 64 and corresponding marker spacing of 5 mm is illustrative and other lcngths fewer than 5 mm or greater than 5 mm may also be utilized as desired. For example, the predetermined spacing distance may range anywhere from about 3 mm to about 30 mni, more preferably in a range from about 5 mm to about 15 mm, depending on the active electrode length, basket leg length, electrode array length parallel to a longitudinal axis of the airway lumen, treatment temperature, time, power, current, voltage, and/or energy settings, and/or polarity configuration.
100501 As mentioned above, in one variation the spacing between these markers 102, 104, 106, 108 may each correspond to a length LE of the active electrodes 64 on basket 62. For instance, a first marker distance LSI between first niarker 102 and second marker 104, a second marker distance LS2 between second niarker 104 and third marker 106, and a third marker distance LS3 between third niarker 106 and fourth marker 108 may each correspond in length to the length LE of active electrodes 64 on basket 62. Moreover, although four markers are illustrated in this example, fewer than four or more than four markers, as desired, niay be utilized along the length of elongate sheath 22 in alternative variations.
100511 Bronchoscope 70 may be electrically coupled 110 to a monitor 112 and/or processor configured to display images 114 received from imaging lumen 76.
As represented on monitor 112, the displayed image corresponds to an image as viewed from the perspective of lumen 76 showing basket 62 projected from the elongate sheath 22. Also illustrated are the visual markings 100 positioned along the sheath 22.
100521 Advantageously, the embodiment of Fig. 4 allows for the amount of tissue being treated by the basket 62 to be easily ascertained with reference to the visual markers 100. In particular, markers 100 improve visibility and/or navigation of locating and placing the treatment electrodes 64 so as to reliably and uniformly apply predetermined axial treatments (e.g., continuous activation treatnients). This in turn niay reduce physician effort or fatigue (e.g., less surgical technique sensitive), total treatnient procedure time, and/or patient discomfort and improve procedure etTicacy.
100531 Referring now to Figs. 5 through 8B, the basket 62 and elongate sheath 22 may be deployed from bronchoscope 70 and positioned distally of bronchoscope 70 along the tissue wall of a bifurcated airway 96. In one example of use, basket 62 may be deployed from bronchoscope 70 and advanced distally relative to bronchoscope working channel 72, as shown in Fig. 6A, while visualizing the passage of markers 102, 104, 106, 108 in monitor 112 directly in real-time, as illustrated in Fig. 613. With basket 62 positioned, it niay be expanded into contact against the surrounding tissue wall 96 and the active electrodes 64 may be activated to heat the airway tissue 120 along a treatment length LE3. The treated tissue length LE3, extending between tissue borders 122, 124, may correspond in length to third marker spacing distance LS3 on elongate sheath 22.
[00541 Once the treatment is completed along tissue length LE3, basket 62 may be retracted and withdrawn proximally relative to bronchoscope 70 whilc visualizing on monitor 112 by one marker length until the fourth marker 108 is no longer visible and third marker 106 is verified as visible in the nlonitor 112, as shown in Fig. 7B. Moving elongate sheath 22 by such a distance also translates basket 62 proximally by one niarker length LS3 and correspondingly translates the active electrodes 64 to an adjacent tissue region proximal to the previously treated tissue length LE3. Once desirably positioned, basket 62 may then again be actuated so as to deploy against the airway wall 96 and activated to heat the airway tissue 121 along a trcatnlent length LE2 which borders treated tissue length LE3 contiguously without overlapping or leaving any gap between the two treated tissue lengths, as shown in Fig. 7A.
100551 Once the tissue along tissue length LE2 has been treated, basket 62 may once again be retracted and withdrawn proximally relative to bronchoscope by another marker length such that third marker 106 is no longer visible and second marker 104 is verified as visible on the monitor 112, as shown in Fig. 8B.
Accordingly, basket 62 is translated proximally by a corresponding distance along the tissue such that the active electrodes 64 are aligned between tissue borders 126 and 128. The basket 62 niay then be activated to treat the tissue region 123 along tissue length LE1 wllich borders treated tissue length LE2, as illustrated in Fig.
8A. 'I'his process of deploying, activating, retracting, and pulling proximally may be repeated, as desired, until first marker 102 is reached or by pulling the bronchoscope proximally with respect to the sheath markers 100 and following the above steps relative to the stationary bronchoscope 70. 'I'hus, longer portions of the tissue may be treated as desired.
100561 The resulting treated tissue may be thus formed into a contiguous length of treated tissue (e.g., LEI, LE2, LE3) which avoids over-treating the tissue by avoiding overlapping regions and avoids the formation of gaps between adjacent tissue lengths. Once the treatment is completed, the basket 62 may be withdrawn proximally into the bronchoscope working channel 72 for withdrawal from the patient or advancement into another region of tissue to be treated. Thus, if the length of the active electrode 64 is 5 mm and the corresponding marker lengths LSI. LS2. LS3 are each 5 mm in length, the tissue may be treated in increments of 5, 10, 15, 20 mm or niore in a contiguous manner depending upon the desired length of tissue to be treated. The predetermined axial treatment (e.g.. LE1, LE2, LE3) may comprise treatment of the lung airways for a length of at least 10 mm, preferably in a range t'rom about 10 nint to about 75 mm, more preferably in a range from about 20 mm to about 30 mm.
100571 It will be appreciated that there are several ways to use the device of the present invention, and as such is not limited by the above example. In an alternative rnethod of use, elongate sheath 22 may be translated distally relative to bronchoscope 70 such that the initial treatment is initiated when first marker 102 is visualized. Accordingly, subsequent portions of tissue may be treated by advancing the basket 62 distally relative to bronchoscope 70 while viewing advancement of the markers on monitor 112. In yet another variation, the elongate sheath 22 and basket 62 may be initially advanced distally until the first marker 102, second marker 104. or third marker 106 is exposed rather than being fully advanced until the fourth marker 108 is exposed. Thus, shorter portions of the tissue may be treated as desired.
100581 Referring now to Figs. 9A through 9F, although markers 100 may be identical, it will be appreciated that they may also be varied in any number of configurations. For example, Fig. 9A illustrates one variation where the markers 130.
132, 134, 136 may be dashed rather than solid. Another variation is shown in Fig. 9B
where the markers may be non-uniform in width, or alternating in width. For instance, inarkers 140. 144 may have a first width while alternating markers 142. 146 may have a second width larger than the first width.
100591 In yet another variation, the markers 150, 152, 154, 156 may be aligned to correspond to the active electrode length, as described above.
Additional half markers 158, 160. 162 may be marked at, e.g., intermediate positions between markers 150. 152, 154, 156, to denote positions where portions of tissue may be treated by overlapping the treatment regions, as shown in Fig. 9C.
100601 Another variation is illustrated in Fig. 9D where markers 170. 172.
174, 176 may be graduated with length measurements, e.g., 5 mm, 10 mm, 15 mm, mm. etc., niuch like an endoscope to facilitate measurement of basket 62 insertion depth or to facilitate measurement of the tissue region (e.g., length of the lung airway). In this manner, a portion of tissue or the depth in which the treatment dcvice is advanced may be ascertained by directly visualizing the elongate sheath 22 extending from the stationary bronchoscope 70. Although the measurenient values are illustrated in 5 mm increments corresponding to the length of the active electrode 64 on the electrode basket 62, any number of incremental values may be marked and delineated either in a corresponding or even non-corresponding manner with respect to the active electrodes, if so desired.
100611 Referring now to Fig. 9E, an elongate sheath 22 having markers whiclt are in various colors to denote particular features associated with that particular marking is illustrated. Although the markers may be colored in the same color (e.g..
black), various colors niay be utilized, particularly to indicate predetermined device states. For example, marker 180 may comprise a first color (e.g., green) to indicate that once niarker 180 is visible, electrode basket 62 is sufficiently advanced relative to the bronchoscope 70 for expansion and/or activation. Additional markers 182, niay also conlprise various colors as well while the proximal marker 186 may also be colored in yet another color (e.g., red) as a visual indication that the elongate sheath 22 should not be advanced any further distal into the airway lung.
100621 In yet another variation, markers 171, 173, 175 (witli graduations 7 mm, 14 mm, 21 mm) may have a length between adjacent markers which is greater than a length of the active electrodes 64 of the treatment device so that intennittent regions ol'tissue may be treated, as shown in Fig. 9F. Still further, the sheath may have a second set of markers 177, 179, 181, 183 that have a different spacing distance. e.g., set to the active electrode 64 length, so that a user may utilize a particular marker set based on a particular anatomy section to be treated.
10063] In these and other variations described herein, each of the markers may be marked on the elongate sheath 22 in various increments and are not limited to just the length of the active electrodes 64, as described above in detail.
Moreover, additional markers may be utilized or as few as a single marker may be utilized depending upon the desired visual indications.
100641 The markers may also serve as a safety feature to discourage the pre-mature deployment of the electrode basket 62 within the bronchoscope 70. For example, the first proximal marker may serve this purpose so as to prevent against any electrical discharge from flowing proximally along the sheath 22, shaft 24 and/or bronchoscope 70, which could potentially result in injury or harm to the patient or user. Additionally, the final proximal marker, which may be positioned along sheath 22 up to 75 mm or more, more preferably up to 50 mm or 30 mm, from the electrode basket 62, may also serve as a visual safety feature to ensure against advancing the electrode basket 62 too deep into the patient body (i.e., beyond bronchoscopic vision), which in turn prevents against any patient harm, such as puncturing of the airway wall into the parenchyma, pneumothorax, pneumomediastinum, etc.
100651 In yet another alternative, at least one of the markers may also be aligned %vith an anatomical landmark within the lung airway to provide not only for alignment of the device but also to facilitate measurement of the lung airway, if so desired. For example, a marker may be aligned with a particular airway bifurcation, colored tissue, cartilage ring, tissue nodule, and the like, so as to ensure against user disorientation due to tidal motion or movement of the access device.
100661 Referring back to Fig. 8B, it will be further appreciated that the markers 102 further allow for user differentiation of the sheath 22 from the insulated electrodes 61, 63, particularly the proximal insulation regions of the basket legs 60.
This visualization is important to ensure proper deployment of the basket electrode 62.
100671 Although certain exemplary embodiments and methods have been dcscribed in some detail, for clarity of understanding and by way of example, it will be apparent from the foregoing disclosure to those skilled in the art that variations, modifications, changes, and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention. For example, the plurality of visual indicators may be located on the device shaft, the energy delivery device may comprise a non-RF source, and/or the expandable energy device may comprise an inflatable balloon member. Still further, the markers of the present invention may be positioned alternatively or additionally on a proximal portion of the sheath or shaft that extends at least partially outside the access device and patient.
Proximal makers may also facilitate quicker and more confident introduction of the shaft into the access device by indicating a measurement of the shaft within the access device. Reference to a singular element, includes the possibility that there are plural of the same elements present. More specifically, as used herein and in the appended claims, the singular forms "a," "an," "said," and "the" include plural referents unless the context clearly dictates otherwise. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
Claims (27)
1. An energy delivery device for use in a body conduit or cavity, the device comprising:
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
an energy delivery element disposed at the distal end of the elongate body;
and a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a body conduit or cavity.
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
an energy delivery element disposed at the distal end of the elongate body;
and a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a body conduit or cavity.
2. The energy delivery device of claim 1, wherein the predetermined axial treatment comprises contiguous, overlapping, intermittent, or combination treatment thereof of the body conduit or cavity with the energy delivery element.
3. The energy delivery device of claim 1, wherein the energy delivery element comprises an electrode, wherein the predetermined spacing distance comprises an active electrode length.
4. The energy delivery device of claim 1, wherein the predetermined spacing comprises a distance in a range from about 3 mm to about 30 mm.
5. The energy delivery device of claim 1, wherein the predetermined spacing comprises a distance of about 5 mm.
6. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two circular bands or rings.
7. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise four circular bands or rings.
8. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two identical markers.
9. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two markers having different colors or non-uniform configurations.
10. The energy delivery device of claim 1, wherein the elongate body comprises a tubular sheath or shaft.
11. The energy delivery device of claim 1, further comprising a proximal marker disposed on the proximal portion of the elongate body.
12. A radio frequency energy delivery device for use in a lung airway so as to treat asthma, the device comprising:
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
a radio frequency electrode disposed at the distal end of the elongate body;
and a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
a radio frequency electrode disposed at the distal end of the elongate body;
and a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
13. A method for delivering energy in a lung airway, the method comprising:
positioning an access device having a visualization element within a lung airway;
advancing an energy delivery device within the access device, wherein a visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element so as to provide a predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
positioning an access device having a visualization element within a lung airway;
advancing an energy delivery device within the access device, wherein a visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element so as to provide a predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
14. The method of claim 13, wherein the predetermined axial treatment comprises contiguous, overlapping, intermittent, or combination treatment thereof of the lung airway with the energy delivery element.
15. The method of claim 13, wherein the predetermined axial treatment comprises contiguous treatment of the lung airway for a length of at least 10 mm.
16. The method of claim 13, further comprising positioning a last visual indicator disposed on the distal portion of the energy delivery device outside the access device as verified with the visualization element.
17. The method of claim 16, further comprising deploying and activating an energy delivery element outside the access device and within a lung airway.
18. The method of claim 17, further comprising retracting the energy delivery element and pulling the energy delivery device in a proximal direction relative to the access device until a next visual indicator disposed on the distal portion of the energy delivery device is verified with the visualization element.
19. The method of claim 18, further comprising repeating the deploying, activating, retracting, and pulling proximal steps so as to provide the predetermined axial treatment in a lung airway relative to the access device.
20. The method of claim 13, further comprising deploying and activating an energy delivery element outside the access device and within a lung airway.
21. The method of claim 20, further comprising retracting the energy delivery element and positioning a second visual indicator disposed on the distal portion of the energy delivery device outside the access device as verified with the visualization element.
22. The method of claim 21, further comprising repeating the deploying, activating, retracting, and positioning steps so as to provide the predetermined axial treatment in a lung airway relative to the access device.
23. The method of claim 13, further comprising preventing pre-mature deployment of the energy delivery element within the access device by visualization of a first visual indicator.
24 24. The method of claim 13, further comprising preventing distal advancement of the energy delivery element beyond a predetermined distance from the access device by visualization of a last visual indicator.
25. The method of claim 13, further comprising aligning the one visual indicator with an anatomical landmark in the lung airway.
26. The method of claim 13, further comprising measuring a length of the lung airway by visual indicator positioning.
27. The method of claim 13, further comprising measuring a depth of the energy delivery element by visual indicator positioning.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/551,639 | 2006-10-20 | ||
| US11/551,639 US7931647B2 (en) | 2006-10-20 | 2006-10-20 | Method of delivering energy to a lung airway using markers |
| PCT/US2007/080736 WO2008051706A2 (en) | 2006-10-20 | 2007-10-08 | Electrode markers and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2667009A1 true CA2667009A1 (en) | 2008-05-02 |
| CA2667009C CA2667009C (en) | 2016-10-04 |
Family
ID=39318966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2667009A Active CA2667009C (en) | 2006-10-20 | 2007-10-08 | Electrode markers and methods of use |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7931647B2 (en) |
| EP (1) | EP2083734B1 (en) |
| JP (1) | JP5422389B2 (en) |
| AU (1) | AU2007309319B2 (en) |
| CA (1) | CA2667009C (en) |
| ES (1) | ES2398980T3 (en) |
| WO (1) | WO2008051706A2 (en) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7027869B2 (en) | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
| US6488673B1 (en) * | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
| US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
| US7992572B2 (en) | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
| US7921855B2 (en) | 1998-01-07 | 2011-04-12 | Asthmatx, Inc. | Method for treating an asthma attack |
| US8181656B2 (en) | 1998-06-10 | 2012-05-22 | Asthmatx, Inc. | Methods for treating airways |
| US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
| US8251070B2 (en) | 2000-03-27 | 2012-08-28 | Asthmatx, Inc. | Methods for treating airways |
| US7104987B2 (en) | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
| US20040226556A1 (en) * | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
| US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
| US20070093802A1 (en) | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
| DE202006021213U1 (en) | 2005-07-21 | 2013-11-08 | Covidien Lp | Apparatus for treating a hollow anatomical structure |
| US7993323B2 (en) | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
| US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
| JP5436423B2 (en) | 2007-07-24 | 2014-03-05 | アスマティックス，インコーポレイテッド | System and method for power control based on impedance detection such as power control for tissue treatment device |
| US20090043301A1 (en) * | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
| US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
| US8483831B1 (en) | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| EP3155995B1 (en) * | 2008-04-03 | 2019-08-07 | Visualase, Inc. | Systems for thermal therapy |
| ES2398052T5 (en) | 2008-05-09 | 2021-10-25 | Nuvaira Inc | Systems for treating a bronchial tree |
| US20100160906A1 (en) * | 2008-12-23 | 2010-06-24 | Asthmatx, Inc. | Expandable energy delivery devices having flexible conductive elements and associated systems and methods |
| EP2493408B1 (en) | 2009-10-27 | 2015-06-24 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| KR101820542B1 (en) | 2009-11-11 | 2018-01-19 | 호라이라 인코포레이티드 | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
| EP3482709B1 (en) * | 2010-04-06 | 2021-07-07 | Nuvaira, Inc. | System for pulmonary treatment |
| WO2011134080A1 (en) | 2010-04-26 | 2011-11-03 | Baylis Medical Company | Electrosurgical device & methods |
| WO2013052501A1 (en) | 2011-10-05 | 2013-04-11 | Innovative Pulmonary Solutions, Inc. | Apparatus for injuring nerve tissue |
| SG11201402610QA (en) | 2011-12-09 | 2014-10-30 | Metavention Inc | Therapeutic neuromodulation of the hepatic system |
| US9770293B2 (en) | 2012-06-04 | 2017-09-26 | Boston Scientific Scimed, Inc. | Systems and methods for treating tissue of a passageway within a body |
| EP2877113B1 (en) | 2012-07-24 | 2018-07-25 | Boston Scientific Scimed, Inc. | Electrodes for tissue treatment |
| WO2014071372A1 (en) | 2012-11-05 | 2014-05-08 | Boston Scientific Scimed, Inc. | Devices for delivering energy to body lumens |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| RU2649527C2 (en) * | 2013-02-05 | 2018-04-03 | Хандок Инк. | Nerve block catheter |
| US9877707B2 (en) | 2013-03-07 | 2018-01-30 | Kyphon SÀRL | Systems and methods for track coagulation |
| WO2014164847A1 (en) * | 2013-03-12 | 2014-10-09 | Boston Scientific Scimed, Inc. | Retrieval device and related methods of use |
| EP4331519A2 (en) | 2013-03-15 | 2024-03-06 | Medtronic Holding Company Sàrl | A system for treating tissue |
| US9814618B2 (en) | 2013-06-06 | 2017-11-14 | Boston Scientific Scimed, Inc. | Devices for delivering energy and related methods of use |
| US9782211B2 (en) | 2013-10-01 | 2017-10-10 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
| US10531893B2 (en) * | 2013-11-12 | 2020-01-14 | Medtronic, Inc. | Extravascular implant tools with open sheath and implant techniques utilizing such tools |
| US10118027B2 (en) | 2013-11-12 | 2018-11-06 | Medtronic, Inc. | Open channel implant tools having an attachment feature and implant techniques utilizing such tools |
| JP5802869B1 (en) * | 2014-01-23 | 2015-11-04 | オリンパス株式会社 | Surgical device |
| EP2959855B1 (en) * | 2014-06-25 | 2019-04-10 | Günter Farin | Electrosurgical resection loop with an exposed part and with a part provided with an insulation |
| US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
| EP3226795B1 (en) * | 2014-12-03 | 2020-08-26 | Metavention, Inc. | Systems for modulating nerves or other tissue |
| US11083491B2 (en) | 2014-12-09 | 2021-08-10 | Medtronic, Inc. | Extravascular implant tools utilizing a bore-in mechanism and implant techniques using such tools |
| US10349978B2 (en) | 2014-12-18 | 2019-07-16 | Medtronic, Inc. | Open channel implant tool with additional lumen and implant techniques utilizing such tools |
| US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
| US10441339B2 (en) | 2015-11-17 | 2019-10-15 | Medtronic Holding Company Sárl | Spinal tissue ablation apparatus, system, and method |
| AU2017289267B2 (en) | 2016-06-27 | 2021-08-12 | Galvanize Therapeutics, Inc. | Generator and a catheter with an electrode and a method for treating a lung passageway |
| US9867978B1 (en) | 2016-09-16 | 2018-01-16 | Precision Neurotechnologies Llc | Conformal electrode arrays for electrophysiologic recording and neural stimulation within the cerebral ventricles |
| US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
| US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
| CN109464186B (en) | 2017-09-08 | 2023-12-22 | 泽丹医疗股份有限公司 | Device and method for treating lung tumors |
| US11350988B2 (en) | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
| USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
| US20190117971A1 (en) * | 2017-10-23 | 2019-04-25 | Cardiac Pacemakers, Inc. | Volume-filling leads for treatment of cancer with electric fields |
| US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
| US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
| US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
| CN113727753A (en) | 2019-04-22 | 2021-11-30 | 波士顿科学国际有限公司 | Electrical stimulation device for cancer treatment |
| CN110507413B (en) * | 2019-09-16 | 2020-06-19 | 浙江大学 | Microwave therapeutic instrument with controllable ablation effective hot area |
| CN115515674A (en) | 2020-02-24 | 2022-12-23 | 波士顿科学国际有限公司 | Systems and methods for treating pancreatic cancer |
Family Cites Families (379)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1155169A (en) | 1914-11-28 | 1915-09-28 | John Starkweather | Surgical instrument. |
| US1207479A (en) | 1915-03-05 | 1916-12-05 | Holger Bisgaard | Self-retaining gatheter. |
| US2072346A (en) | 1934-10-04 | 1937-03-02 | Ward R Smith | Drainage tube |
| US3320957A (en) | 1964-05-21 | 1967-05-23 | Sokolik Edward | Surgical instrument |
| US3568659A (en) | 1968-09-24 | 1971-03-09 | James N Karnegis | Disposable percutaneous intracardiac pump and method of pumping blood |
| US3667476A (en) | 1970-04-27 | 1972-06-06 | Bio Data Corp | Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature |
| US3692029A (en) | 1971-05-03 | 1972-09-19 | Edwin Lloyd Adair | Retention catheter and suprapubic shunt |
| JPS5394480A (en) * | 1977-01-31 | 1978-08-18 | Olympus Optical Co | Method of forming index of long insertion |
| JPS5618342Y2 (en) * | 1979-04-26 | 1981-04-30 | ||
| US4565200A (en) | 1980-09-24 | 1986-01-21 | Cosman Eric R | Universal lesion and recording electrode system |
| JPS57168656A (en) | 1981-04-10 | 1982-10-18 | Medos Kenkyusho Kk | Endoscope laser coagulator |
| US4706688A (en) | 1981-05-18 | 1987-11-17 | Don Michael T Anthony | Non-invasive cardiac device |
| US4612934A (en) | 1981-06-30 | 1986-09-23 | Borkan William N | Non-invasive multiprogrammable tissue stimulator |
| US4584998A (en) | 1981-09-11 | 1986-04-29 | Mallinckrodt, Inc. | Multi-purpose tracheal tube |
| DE3247793C2 (en) | 1981-12-31 | 1986-01-09 | Harald 7200 Tuttlingen Maslanka | High frequency surgical loop electrode |
| US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
| US4462402A (en) * | 1982-11-15 | 1984-07-31 | Minnesota Mining And Manufacturing Company | Method and anchor for anchoring |
| US4567882A (en) | 1982-12-06 | 1986-02-04 | Vanderbilt University | Method for locating the illuminated tip of an endotracheal tube |
| US4522212A (en) | 1983-11-14 | 1985-06-11 | Mansfield Scientific, Inc. | Endocardial electrode |
| FR2561929B1 (en) | 1984-03-27 | 1989-02-03 | Atesys | IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION |
| JPS6148350A (en) | 1984-08-15 | 1986-03-10 | オリンパス光学工業株式会社 | Medical laser apparatus |
| US4799479A (en) | 1984-10-24 | 1989-01-24 | The Beth Israel Hospital Association | Method and apparatus for angioplasty |
| US5019075A (en) | 1984-10-24 | 1991-05-28 | The Beth Israel Hospital | Method and apparatus for angioplasty |
| US4862886A (en) | 1985-05-08 | 1989-09-05 | Summit Technology Inc. | Laser angioplasty |
| US4976709A (en) | 1988-12-15 | 1990-12-11 | Sand Bruce J | Method for collagen treatment |
| US4643186A (en) | 1985-10-30 | 1987-02-17 | Rca Corporation | Percutaneous transluminal microwave catheter angioplasty |
| US4827935A (en) | 1986-04-24 | 1989-05-09 | Purdue Research Foundation | Demand electroventilator |
| US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
| US5231995A (en) | 1986-11-14 | 1993-08-03 | Desai Jawahar M | Method for catheter mapping and ablation |
| US5215103A (en) | 1986-11-14 | 1993-06-01 | Desai Jawahar M | Catheter for mapping and ablation and method therefor |
| US4802492A (en) | 1987-03-11 | 1989-02-07 | National Jewish Center For Immunology And Respiratory Medicine | Method for determining respiratory function |
| JPS6446056U (en) | 1987-09-17 | 1989-03-22 | ||
| US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
| US5010892A (en) | 1988-05-04 | 1991-04-30 | Triangle Research And Development Corp. | Body lumen measuring instrument |
| US4967765A (en) | 1988-07-28 | 1990-11-06 | Bsd Medical Corporation | Urethral inserted applicator for prostate hyperthermia |
| US4920978A (en) | 1988-08-31 | 1990-05-01 | Triangle Research And Development Corporation | Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia |
| US5191883A (en) | 1988-10-28 | 1993-03-09 | Prutech Research And Development Partnership Ii | Device for heating tissue in a patient's body |
| US4955377A (en) | 1988-10-28 | 1990-09-11 | Lennox Charles D | Device and method for heating tissue in a patient's body |
| US4945912A (en) | 1988-11-25 | 1990-08-07 | Sensor Electronics, Inc. | Catheter with radiofrequency heating applicator |
| US5779698A (en) | 1989-01-18 | 1998-07-14 | Applied Medical Resources Corporation | Angioplasty catheter system and method for making same |
| US5433730A (en) | 1989-05-03 | 1995-07-18 | Intermedics, Inc. | Conductive pouch electrode for defibrillation |
| US5152286A (en) | 1989-05-08 | 1992-10-06 | Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" | Method of microwave resonance therapy and device therefor |
| US5074860A (en) | 1989-06-09 | 1991-12-24 | Heraeus Lasersonics, Inc. | Apparatus for directing 10.6 micron laser radiation to a tissue site |
| US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| US5562608A (en) | 1989-08-28 | 1996-10-08 | Biopulmonics, Inc. | Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
| US5057105A (en) | 1989-08-28 | 1991-10-15 | The University Of Kansas Med Center | Hot tip catheter assembly |
| EP0490979B1 (en) | 1989-09-08 | 1996-11-13 | Boston Scientific Corporation | Physiologic low stress angioplasty |
| US5100388A (en) | 1989-09-15 | 1992-03-31 | Interventional Thermodynamics, Inc. | Method and device for thermal ablation of hollow body organs |
| US5117828A (en) | 1989-09-25 | 1992-06-02 | Arzco Medical Electronics, Inc. | Expandable esophageal catheter |
| US5203832A (en) | 1989-11-17 | 1993-04-20 | Long Manufacturing Ltd. | Circumferential flow heat exchanger |
| US5254088A (en) | 1990-02-02 | 1993-10-19 | Ep Technologies, Inc. | Catheter steering mechanism |
| FR2659240B1 (en) | 1990-03-06 | 1997-07-04 | Daniel Galley | EPIDURAL ELECTRODE SYSTEM CALLED TO BE INTRODUCED INTO THE EPIDURAL SPACE. |
| US5549559A (en) | 1990-03-22 | 1996-08-27 | Argomed Ltd. | Thermal treatment apparatus |
| US5096916A (en) | 1990-05-07 | 1992-03-17 | Aegis Technology, Inc. | Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
| US5236413B1 (en) | 1990-05-07 | 1996-06-18 | Andrew J Feiring | Method and apparatus for inducing the permeation of medication into internal tissue |
| US5078716A (en) | 1990-05-11 | 1992-01-07 | Doll Larry F | Electrosurgical apparatus for resecting abnormal protruding growth |
| US5056519A (en) | 1990-05-14 | 1991-10-15 | Vince Dennis J | Unilateral diaphragmatic pacer |
| US5265604A (en) | 1990-05-14 | 1993-11-30 | Vince Dennis J | Demand - diaphragmatic pacing (skeletal muscle pressure modified) |
| US5103804A (en) | 1990-07-03 | 1992-04-14 | Boston Scientific Corporation | Expandable tip hemostatic probes and the like |
| US5188602A (en) | 1990-07-12 | 1993-02-23 | Interventional Thermodynamics, Inc. | Method and device for delivering heat to hollow body organs |
| US5135517A (en) | 1990-07-19 | 1992-08-04 | Catheter Research, Inc. | Expandable tube-positioning apparatus |
| US5100423A (en) | 1990-08-21 | 1992-03-31 | Medical Engineering & Development Institute, Inc. | Ablation catheter |
| EP0548122A1 (en) | 1990-09-14 | 1993-06-30 | American Medical Systems, Inc. | Combined hyperthermia and dilation catheter |
| US5170803A (en) | 1990-09-28 | 1992-12-15 | Brunswick Biomedical Technologies, Inc. | Esophageal displacement electrode |
| US5053033A (en) | 1990-10-10 | 1991-10-01 | Boston Advanced Technologies, Inc. | Inhibition of restenosis by ultraviolet radiation |
| US5174288A (en) | 1990-11-30 | 1992-12-29 | Medtronic, Inc. | Method and apparatus for cardiac defibrillation |
| US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
| US5465717A (en) | 1991-02-15 | 1995-11-14 | Cardiac Pathways Corporation | Apparatus and Method for ventricular mapping and ablation |
| US5415166A (en) | 1991-02-15 | 1995-05-16 | Cardiac Pathways Corporation | Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method |
| US5345936A (en) | 1991-02-15 | 1994-09-13 | Cardiac Pathways Corporation | Apparatus with basket assembly for endocardial mapping |
| US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
| RU2091054C1 (en) | 1991-03-25 | 1997-09-27 | Владивостокский государственный медицинский университет | Method for treating asthmatic bronchitis in children affected with constitutional diathesis |
| US5116864A (en) | 1991-04-09 | 1992-05-26 | Indiana University Foundation | Method for preventing restenosis following reconfiguration of body vessels |
| AU669670B2 (en) | 1991-04-10 | 1996-06-20 | British Technology Group Usa, Inc. | Defibrillator and demand pacer catheter and method |
| US5255678A (en) | 1991-06-21 | 1993-10-26 | Ecole Polytechnique | Mapping electrode balloon |
| US5383917A (en) | 1991-07-05 | 1995-01-24 | Jawahar M. Desai | Device and method for multi-phase radio-frequency ablation |
| JP3171628B2 (en) * | 1991-12-26 | 2001-05-28 | オリンパス光学工業株式会社 | High frequency knife for endoscope |
| US5366443A (en) | 1992-01-07 | 1994-11-22 | Thapliyal And Eggers Partners | Method and apparatus for advancing catheters through occluded body lumens |
| US6053172A (en) | 1995-06-07 | 2000-04-25 | Arthrocare Corporation | Systems and methods for electrosurgical sinus surgery |
| US6159194A (en) | 1992-01-07 | 2000-12-12 | Arthrocare Corporation | System and method for electrosurgical tissue contraction |
| US5699796A (en) | 1993-01-29 | 1997-12-23 | Cardima, Inc. | High resolution intravascular signal detection |
| RU2053814C1 (en) | 1992-02-11 | 1996-02-10 | Новиков Валерий Николаевич | Method for treatment of local endobronchitis |
| US5540681A (en) | 1992-04-10 | 1996-07-30 | Medtronic Cardiorhythm | Method and system for radiofrequency ablation of tissue |
| US5269758A (en) | 1992-04-29 | 1993-12-14 | Taheri Syde A | Intravascular catheter and method for treatment of hypothermia |
| US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
| US5255679A (en) | 1992-06-02 | 1993-10-26 | Cardiac Pathways Corporation | Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method |
| US5324284A (en) | 1992-06-05 | 1994-06-28 | Cardiac Pathways, Inc. | Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method |
| US5281218A (en) | 1992-06-05 | 1994-01-25 | Cardiac Pathways Corporation | Catheter having needle electrode for radiofrequency ablation |
| US5772590A (en) | 1992-06-30 | 1998-06-30 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire |
| US5411025A (en) | 1992-06-30 | 1995-05-02 | Cordis Webster, Inc. | Cardiovascular catheter with laterally stable basket-shaped electrode array |
| US5782239A (en) | 1992-06-30 | 1998-07-21 | Cordis Webster, Inc. | Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire |
| US5630794A (en) | 1992-08-12 | 1997-05-20 | Vidamed, Inc. | Catheter tip and method of manufacturing |
| GB9219102D0 (en) | 1992-09-09 | 1992-10-21 | Fairfax Andrew J | Flowmeters |
| US5311866A (en) | 1992-09-23 | 1994-05-17 | Endocardial Therapeutics, Inc. | Heart mapping catheter |
| US5309910A (en) | 1992-09-25 | 1994-05-10 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
| US5293869A (en) | 1992-09-25 | 1994-03-15 | Ep Technologies, Inc. | Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole |
| US5313943A (en) | 1992-09-25 | 1994-05-24 | Ep Technologies, Inc. | Catheters and methods for performing cardiac diagnosis and treatment |
| US5471982A (en) | 1992-09-29 | 1995-12-05 | Ep Technologies, Inc. | Cardiac mapping and ablation systems |
| US6086581A (en) | 1992-09-29 | 2000-07-11 | Ep Technologies, Inc. | Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart |
| DE69315704T3 (en) | 1992-10-01 | 2002-08-01 | Cardiac Pacemakers Inc | STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES |
| US5431696A (en) | 1992-10-13 | 1995-07-11 | Atlee, Iii; John L. | Esophageal probe for transeophageal cardiac stimulation |
| US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
| US5720745A (en) * | 1992-11-24 | 1998-02-24 | Erbe Electromedizin Gmbh | Electrosurgical unit and method for achieving coagulation of biological tissue |
| US5348554A (en) | 1992-12-01 | 1994-09-20 | Cardiac Pathways Corporation | Catheter for RF ablation with cooled electrode |
| US5545161A (en) | 1992-12-01 | 1996-08-13 | Cardiac Pathways Corporation | Catheter for RF ablation having cooled electrode with electrically insulated sleeve |
| US5256141A (en) | 1992-12-22 | 1993-10-26 | Nelson Gencheff | Biological material deployment method and apparatus |
| US5706809A (en) | 1993-01-29 | 1998-01-13 | Cardima, Inc. | Method and system for using multiple intravascular sensing devices to detect electrical activity |
| US5823189A (en) | 1993-03-16 | 1998-10-20 | Ep Technologies, Inc. | Multiple electrode support structures with spline elements and over-molded hub |
| US5725525A (en) | 1993-03-16 | 1998-03-10 | Ep Technologies, Inc. | Multiple electrode support structures with integral hub and spline elements |
| WO1994021170A1 (en) | 1993-03-16 | 1994-09-29 | Ep Technologies, Inc. | Flexible circuit assemblies employing ribbon cable |
| US5893847A (en) | 1993-03-16 | 1999-04-13 | Ep Technologies, Inc. | Multiple electrode support structures with slotted hub and hoop spline elements |
| JP3423719B2 (en) | 1993-03-16 | 2003-07-07 | ボストン サイエンティフィック リミテッド | Multiple electrode support mechanism |
| US5417687A (en) | 1993-04-30 | 1995-05-23 | Medical Scientific, Inc. | Bipolar electrosurgical trocar |
| US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
| US5456667A (en) | 1993-05-20 | 1995-10-10 | Advanced Cardiovascular Systems, Inc. | Temporary stenting catheter with one-piece expandable segment |
| US5860974A (en) | 1993-07-01 | 1999-01-19 | Boston Scientific Corporation | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
| US5571088A (en) | 1993-07-01 | 1996-11-05 | Boston Scientific Corporation | Ablation catheters |
| WO1995001751A1 (en) | 1993-07-01 | 1995-01-19 | Boston Scientific Corporation | Imaging, electrical potential sensing, and ablation catheters |
| US5562619A (en) | 1993-08-19 | 1996-10-08 | Boston Scientific Corporation | Deflectable catheter |
| US5464404A (en) | 1993-09-20 | 1995-11-07 | Abela Laser Systems, Inc. | Cardiac ablation catheters and method |
| US5396887A (en) | 1993-09-23 | 1995-03-14 | Cardiac Pathways Corporation | Apparatus and method for detecting contact pressure |
| US5908446A (en) | 1994-07-07 | 1999-06-01 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-port introducer for use therewith |
| US5607462A (en) | 1993-09-24 | 1997-03-04 | Cardiac Pathways Corporation | Catheter assembly, catheter and multi-catheter introducer for use therewith |
| US5626618A (en) | 1993-09-24 | 1997-05-06 | The Ohio State University | Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring |
| US5415656A (en) | 1993-09-28 | 1995-05-16 | American Medical Systems, Inc. | Electrosurgical apparatus |
| US5400783A (en) | 1993-10-12 | 1995-03-28 | Cardiac Pathways Corporation | Endocardial mapping apparatus with rotatable arm and method |
| US5582609A (en) | 1993-10-14 | 1996-12-10 | Ep Technologies, Inc. | Systems and methods for forming large lesions in body tissue using curvilinear electrode elements |
| US5881727A (en) | 1993-10-14 | 1999-03-16 | Ep Technologies, Inc. | Integrated cardiac mapping and ablation probe |
| WO1995010322A1 (en) | 1993-10-15 | 1995-04-20 | Ep Technologies, Inc. | Creating complex lesion patterns in body tissue |
| US5991650A (en) | 1993-10-15 | 1999-11-23 | Ep Technologies, Inc. | Surface coatings for catheters, direct contacting diagnostic and therapeutic devices |
| US5545193A (en) | 1993-10-15 | 1996-08-13 | Ep Technologies, Inc. | Helically wound radio-frequency emitting electrodes for creating lesions in body tissue |
| US5409469A (en) | 1993-11-04 | 1995-04-25 | Medtronic, Inc. | Introducer system having kink resistant splittable sheath |
| US6071280A (en) | 1993-11-08 | 2000-06-06 | Rita Medical Systems, Inc. | Multiple electrode ablation apparatus |
| US5599346A (en) | 1993-11-08 | 1997-02-04 | Zomed International, Inc. | RF treatment system |
| US6641580B1 (en) | 1993-11-08 | 2003-11-04 | Rita Medical Systems, Inc. | Infusion array ablation apparatus |
| US6438400B1 (en) | 1993-12-06 | 2002-08-20 | Heska Corporation | Electrode for evaluating cardiac functions via esophagus |
| US5423812A (en) | 1994-01-31 | 1995-06-13 | Ellman; Alan G. | Electrosurgical stripping electrode for palatopharynx tissue |
| US6216043B1 (en) | 1994-03-04 | 2001-04-10 | Ep Technologies, Inc. | Asymmetric multiple electrode support structures |
| US5394880A (en) | 1994-03-17 | 1995-03-07 | Atlee, Iii; John L. | Esophageal stethoscope |
| US5598848A (en) | 1994-03-31 | 1997-02-04 | Ep Technologies, Inc. | Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium |
| SE9401267D0 (en) | 1994-04-14 | 1994-04-14 | Siemens Elema Ab | The electrode device |
| US5458596A (en) | 1994-05-06 | 1995-10-17 | Dorsal Orthopedic Corporation | Method and apparatus for controlled contraction of soft tissue |
| US5807308A (en) | 1996-02-23 | 1998-09-15 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
| US5547469A (en) | 1994-05-13 | 1996-08-20 | Boston Scientific Corporation | Apparatus for performing diagnostic and therapeutic modalities in the biliary tree |
| US5478309A (en) | 1994-05-27 | 1995-12-26 | William P. Sweezer, Jr. | Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery |
| US5827277A (en) | 1994-06-24 | 1998-10-27 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates |
| US5505730A (en) | 1994-06-24 | 1996-04-09 | Stuart D. Edwards | Thin layer ablation apparatus |
| US6009877A (en) | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
| US5843077A (en) | 1994-06-24 | 1998-12-01 | Somnus Medical Technologies, Inc. | Minimally invasive apparatus for internal ablation of turbinates with surface cooling |
| US6092528A (en) | 1994-06-24 | 2000-07-25 | Edwards; Stuart D. | Method to treat esophageal sphincters |
| US5681308A (en) | 1994-06-24 | 1997-10-28 | Stuart D. Edwards | Ablation apparatus for cardiac chambers |
| US6056744A (en) | 1994-06-24 | 2000-05-02 | Conway Stuart Medical, Inc. | Sphincter treatment apparatus |
| US6006755A (en) | 1994-06-24 | 1999-12-28 | Edwards; Stuart D. | Method to detect and treat aberrant myoelectric activity |
| US5680860A (en) | 1994-07-07 | 1997-10-28 | Cardiac Pathways Corporation | Mapping and/or ablation catheter with coilable distal extremity and method for using same |
| US5623940A (en) | 1994-08-02 | 1997-04-29 | S.L.T. Japan Co., Ltd. | Catheter apparatus with a sensor |
| US5454782A (en) | 1994-08-11 | 1995-10-03 | Perkins; Rodney C. | Translumenal circumferential energy delivery device |
| US5522862A (en) | 1994-09-21 | 1996-06-04 | Medtronic, Inc. | Method and apparatus for treating obstructive sleep apnea |
| US5549655A (en) | 1994-09-21 | 1996-08-27 | Medtronic, Inc. | Method and apparatus for synchronized treatment of obstructive sleep apnea |
| US6142994A (en) | 1994-10-07 | 2000-11-07 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body |
| US5885278A (en) | 1994-10-07 | 1999-03-23 | E.P. Technologies, Inc. | Structures for deploying movable electrode elements |
| US7175619B2 (en) * | 1994-10-07 | 2007-02-13 | Boston Scientific Scimed, Inc. | Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface |
| US5836947A (en) | 1994-10-07 | 1998-11-17 | Ep Technologies, Inc. | Flexible structures having movable splines for supporting electrode elements |
| US5740808A (en) | 1996-10-28 | 1998-04-21 | Ep Technologies, Inc | Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions |
| US5722401A (en) | 1994-10-19 | 1998-03-03 | Cardiac Pathways Corporation | Endocardial mapping and/or ablation catheter probe |
| US5899882A (en) | 1994-10-27 | 1999-05-04 | Novoste Corporation | Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient |
| US5814029A (en) | 1994-11-03 | 1998-09-29 | Daig Corporation | Guiding introducer system for use in ablation and mapping procedures in the left ventricle |
| US5792064A (en) | 1995-02-17 | 1998-08-11 | Panescu; Dorin | Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation |
| US5595183A (en) | 1995-02-17 | 1997-01-21 | Ep Technologies, Inc. | Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes |
| US5722416A (en) | 1995-02-17 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites |
| US5630425A (en) | 1995-02-17 | 1997-05-20 | Ep Technologies, Inc. | Systems and methods for adaptive filtering artifacts from composite signals |
| US5711305A (en) | 1995-02-17 | 1998-01-27 | Ep Technologies, Inc. | Systems and methods for acquiring endocardially or epicardially paced electrocardiograms |
| US5601088A (en) | 1995-02-17 | 1997-02-11 | Ep Technologies, Inc. | Systems and methods for filtering artifacts from composite signals |
| US5605157A (en) | 1995-02-17 | 1997-02-25 | Ep Technologies, Inc. | Systems and methods for filtering signals derived from biological events |
| EP0809463B1 (en) | 1995-02-17 | 2002-07-10 | Boston Scientific Limited | Systems for making time-sequential measurements of biological events |
| US6409722B1 (en) | 1998-07-07 | 2002-06-25 | Medtronic, Inc. | Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue |
| WO1996026671A1 (en) | 1995-02-28 | 1996-09-06 | Boston Scientific Corporation | Polymeric implements for torque transmission |
| US5868740A (en) | 1995-03-24 | 1999-02-09 | Board Of Regents-Univ Of Nebraska | Method for volumetric tissue ablation |
| US5620438A (en) | 1995-04-20 | 1997-04-15 | Angiomedics Ii Incorporated | Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis |
| US5678535A (en) | 1995-04-21 | 1997-10-21 | Dimarco; Anthony Fortunato | Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient |
| US5607419A (en) | 1995-04-24 | 1997-03-04 | Angiomedics Ii Inc. | Method and apparatus for treating vessel wall with UV radiation following angioplasty |
| WO1996033763A2 (en) | 1995-04-28 | 1996-10-31 | Target Therapeutics, Inc. | High performance braided catheter |
| US5681280A (en) | 1995-05-02 | 1997-10-28 | Heart Rhythm Technologies, Inc. | Catheter control system |
| US5755753A (en) | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
| US6251104B1 (en) | 1995-05-10 | 2001-06-26 | Eclipse Surgical Technologies, Inc. | Guiding catheter system for ablating heart tissue |
| US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
| US6837888B2 (en) | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
| US5868737A (en) | 1995-06-09 | 1999-02-09 | Engineering Research & Associates, Inc. | Apparatus and method for determining ablation |
| US5697925A (en) | 1995-06-09 | 1997-12-16 | Engineering & Research Associates, Inc. | Apparatus and method for thermal ablation |
| US5782795A (en) | 1995-06-30 | 1998-07-21 | Xomed Surgical Products, Inc. | Surgical suction cutting instrument with internal irrigation |
| WO1997004702A1 (en) | 1995-07-28 | 1997-02-13 | Ep Technologies, Inc. | Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue |
| US6023638A (en) | 1995-07-28 | 2000-02-08 | Scimed Life Systems, Inc. | System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue |
| US5782827A (en) | 1995-08-15 | 1998-07-21 | Rita Medical Systems, Inc. | Multiple antenna ablation apparatus and method with multiple sensor feedback |
| US5624439A (en) | 1995-08-18 | 1997-04-29 | Somnus Medical Technologies, Inc. | Method and apparatus for treatment of air way obstructions |
| US6210367B1 (en) | 1995-09-06 | 2001-04-03 | Microwave Medical Systems, Inc. | Intracorporeal microwave warming method and apparatus |
| US6496738B2 (en) | 1995-09-06 | 2002-12-17 | Kenneth L. Carr | Dual frequency microwave heating apparatus |
| US5848972A (en) | 1995-09-15 | 1998-12-15 | Children's Medical Center Corporation | Method for endocardial activation mapping using a multi-electrode catheter |
| US6198970B1 (en) | 1995-10-27 | 2001-03-06 | Esd Limited Liability Company | Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation |
| US5833632A (en) | 1995-12-07 | 1998-11-10 | Sarcos, Inc. | Hollow guide wire apparatus catheters |
| US5837001A (en) | 1995-12-08 | 1998-11-17 | C. R. Bard | Radio frequency energy delivery system for multipolar electrode catheters |
| US5891135A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures |
| US5891136A (en) | 1996-01-19 | 1999-04-06 | Ep Technologies, Inc. | Expandable-collapsible mesh electrode structures |
| US5846238A (en) | 1996-01-19 | 1998-12-08 | Ep Technologies, Inc. | Expandable-collapsible electrode structures with distal end steering or manipulation |
| US5904711A (en) | 1996-02-08 | 1999-05-18 | Heartport, Inc. | Expandable thoracoscopic defibrillation catheter system and method |
| US5730726A (en) | 1996-03-04 | 1998-03-24 | Klingenstein; Ralph James | Apparatus and method for removing fecal impaction |
| US6036687A (en) | 1996-03-05 | 2000-03-14 | Vnus Medical Technologies, Inc. | Method and apparatus for treating venous insufficiency |
| US6139527A (en) | 1996-03-05 | 2000-10-31 | Vnus Medical Technologies, Inc. | Method and apparatus for treating hemorrhoids |
| US6152899A (en) | 1996-03-05 | 2000-11-28 | Vnus Medical Technologies, Inc. | Expandable catheter having improved electrode design, and method for applying energy |
| US6033397A (en) | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
| US5755760A (en) | 1996-03-11 | 1998-05-26 | Medtronic, Inc. | Deflectable catheter |
| US5699799A (en) | 1996-03-26 | 1997-12-23 | Siemens Corporate Research, Inc. | Automatic determination of the curved axis of a 3-D tube-shaped object in image volume |
| US5863291A (en) | 1996-04-08 | 1999-01-26 | Cardima, Inc. | Linear ablation assembly |
| US5979456A (en) | 1996-04-22 | 1999-11-09 | Magovern; George J. | Apparatus and method for reversibly reshaping a body part |
| US5810807A (en) | 1996-05-22 | 1998-09-22 | Ganz; Robert A. | Sphincterotome with deflectable cutting plane and method of using the same |
| US5824026A (en) | 1996-06-12 | 1998-10-20 | The Spectranetics Corporation | Catheter for delivery of electric energy and a process for manufacturing same |
| US6743197B1 (en) | 1996-07-10 | 2004-06-01 | Novasys Medical, Inc. | Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems |
| US5882346A (en) | 1996-07-15 | 1999-03-16 | Cardiac Pathways Corporation | Shapable catheter using exchangeable core and method of use |
| US5810806A (en) * | 1996-08-29 | 1998-09-22 | Ethicon Endo-Surgery | Methods and devices for collection of soft tissue |
| US5755716A (en) * | 1996-08-30 | 1998-05-26 | Garito; Jon C. | Method for using an electrosurgical electrode for treating glaucoma |
| US5855577A (en) | 1996-09-17 | 1999-01-05 | Eclipse Surgical Technologies, Inc. | Bow shaped catheter |
| US5906636A (en) | 1996-09-20 | 1999-05-25 | Texas Heart Institute | Heat treatment of inflamed tissue |
| US6464697B1 (en) | 1998-02-19 | 2002-10-15 | Curon Medical, Inc. | Stomach and adjoining tissue regions in the esophagus |
| US6016437A (en) | 1996-10-21 | 2000-01-18 | Irvine Biomedical, Inc. | Catheter probe system with inflatable soft shafts |
| JP4162716B2 (en) | 1996-10-23 | 2008-10-08 | Ｔｄｋ株式会社 | Method for manufacturing battery electrode |
| US5904651A (en) | 1996-10-28 | 1999-05-18 | Ep Technologies, Inc. | Systems and methods for visualizing tissue during diagnostic or therapeutic procedures |
| US5722403A (en) | 1996-10-28 | 1998-03-03 | Ep Technologies, Inc. | Systems and methods using a porous electrode for ablating and visualizing interior tissue regions |
| US5908445A (en) | 1996-10-28 | 1999-06-01 | Ep Technologies, Inc. | Systems for visualizing interior tissue regions including an actuator to move imaging element |
| US5752518A (en) | 1996-10-28 | 1998-05-19 | Ep Technologies, Inc. | Systems and methods for visualizing interior regions of the body |
| US5779669A (en) | 1996-10-28 | 1998-07-14 | C. R. Bard, Inc. | Steerable catheter with fixed curve |
| US5848969A (en) | 1996-10-28 | 1998-12-15 | Ep Technologies, Inc. | Systems and methods for visualizing interior tissue regions using expandable imaging structures |
| US5919147A (en) | 1996-11-01 | 1999-07-06 | Jain; Krishna M. | Method and apparatus for measuring the vascular diameter of a vessel |
| US6073052A (en) | 1996-11-15 | 2000-06-06 | Zelickson; Brian D. | Device and method for treatment of gastroesophageal reflux disease |
| US6071279A (en) | 1996-12-19 | 2000-06-06 | Ep Technologies, Inc. | Branched structures for supporting multiple electrode elements |
| US5968087A (en) | 1996-12-19 | 1999-10-19 | Medtronic, Inc. | Multi-component lead body for medical electrical leads |
| US5730741A (en) | 1997-02-07 | 1998-03-24 | Eclipse Surgical Technologies, Inc. | Guided spiral catheter |
| US5873865A (en) | 1997-02-07 | 1999-02-23 | Eclipse Surgical Technologies, Inc. | Spiral catheter with multiple guide holes |
| US6056769A (en) | 1997-02-11 | 2000-05-02 | Biointerventional Corporation | Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method |
| US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
| US5999855A (en) | 1997-02-28 | 1999-12-07 | Dimarco; Anthony F. | Method and apparatus for electrical activation of the expiratory muscles to restore cough |
| US5897554A (en) | 1997-03-01 | 1999-04-27 | Irvine Biomedical, Inc. | Steerable catheter having a loop electrode |
| USH1905H (en) | 1997-03-21 | 2000-10-03 | Medtronic, Inc. | Mechanism for adjusting the exposed surface area and position of an electrode along a lead body |
| US5954661A (en) | 1997-03-31 | 1999-09-21 | Thomas Jefferson University | Tissue characterization and treatment using pacing |
| US7027869B2 (en) * | 1998-01-07 | 2006-04-11 | Asthmatx, Inc. | Method for treating an asthma attack |
| US6273907B1 (en) | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
| US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
| US6283988B1 (en) | 1997-04-07 | 2001-09-04 | Broncus Technologies, Inc. | Bronchial stenter having expandable electrodes |
| US6200333B1 (en) | 1997-04-07 | 2001-03-13 | Broncus Technologies, Inc. | Bronchial stenter |
| US6488673B1 (en) | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
| US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
| US6083255A (en) | 1997-04-07 | 2000-07-04 | Broncus Technologies, Inc. | Bronchial stenter |
| US6411852B1 (en) * | 1997-04-07 | 2002-06-25 | Broncus Technologies, Inc. | Modification of airways by application of energy |
| US7425212B1 (en) | 1998-06-10 | 2008-09-16 | Asthmatx, Inc. | Devices for modification of airways by transfer of energy |
| US5876340A (en) | 1997-04-17 | 1999-03-02 | Irvine Biomedical, Inc. | Ablation apparatus with ultrasonic imaging capabilities |
| US5971983A (en) | 1997-05-09 | 1999-10-26 | The Regents Of The University Of California | Tissue ablation device and method of use |
| US6024740A (en) | 1997-07-08 | 2000-02-15 | The Regents Of The University Of California | Circumferential ablation device assembly |
| US6050992A (en) | 1997-05-19 | 2000-04-18 | Radiotherapeutics Corporation | Apparatus and method for treating tissue with multiple electrodes |
| US6217576B1 (en) | 1997-05-19 | 2001-04-17 | Irvine Biomedical Inc. | Catheter probe for treating focal atrial fibrillation in pulmonary veins |
| US5876399A (en) | 1997-05-28 | 1999-03-02 | Irvine Biomedical, Inc. | Catheter system and methods thereof |
| US5921999A (en) | 1997-06-03 | 1999-07-13 | Dileo; Frank | System and method employing a pie-zoelectric crystal and transverse oscillation to perform a capsulotomy |
| US6251109B1 (en) | 1997-06-27 | 2001-06-26 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
| US5824359A (en) | 1997-06-30 | 1998-10-20 | Becton Dickinson And Company | Medical device lubricant containing lecithin |
| US6547788B1 (en) | 1997-07-08 | 2003-04-15 | Atrionx, Inc. | Medical device with sensor cooperating with expandable member |
| US6500174B1 (en) | 1997-07-08 | 2002-12-31 | Atrionix, Inc. | Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member |
| US6014579A (en) | 1997-07-21 | 2000-01-11 | Cardiac Pathways Corp. | Endocardial mapping catheter with movable electrode |
| US6010500A (en) | 1997-07-21 | 2000-01-04 | Cardiac Pathways Corporation | Telescoping apparatus and method for linear lesion ablation |
| US6626903B2 (en) | 1997-07-24 | 2003-09-30 | Rex Medical, L.P. | Surgical biopsy device |
| US5891138A (en) | 1997-08-11 | 1999-04-06 | Irvine Biomedical, Inc. | Catheter system having parallel electrodes |
| US5916235A (en) | 1997-08-13 | 1999-06-29 | The Regents Of The University Of California | Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities |
| US5954717A (en) | 1997-09-25 | 1999-09-21 | Radiotherapeutics Corporation | Method and system for heating solid tissue |
| US6045549A (en) | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
| US6645200B1 (en) | 1997-10-10 | 2003-11-11 | Scimed Life Systems, Inc. | Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same |
| US6071281A (en) | 1998-05-05 | 2000-06-06 | Ep Technologies, Inc. | Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same |
| JPH11113924A (en) * | 1997-10-13 | 1999-04-27 | Olympus Optical Co Ltd | High frequency knife for endoscope |
| US6917834B2 (en) | 1997-12-03 | 2005-07-12 | Boston Scientific Scimed, Inc. | Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates |
| US6200311B1 (en) | 1998-01-20 | 2001-03-13 | Eclipse Surgical Technologies, Inc. | Minimally invasive TMR device |
| US6258087B1 (en) * | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
| US6142993A (en) | 1998-02-27 | 2000-11-07 | Ep Technologies, Inc. | Collapsible spline structure using a balloon as an expanding actuator |
| CA2320109A1 (en) | 1998-03-06 | 1999-09-10 | Curon Medical, Inc. | Apparatus to electrosurgically treat esophageal sphincters |
| AU3104999A (en) | 1998-03-19 | 1999-10-11 | Oratec Interventions, Inc. | Catheter for delivery of energy to a surgical site |
| US6338727B1 (en) | 1998-08-13 | 2002-01-15 | Alsius Corporation | Indwelling heat exchange catheter and method of using same |
| US6003517A (en) | 1998-04-30 | 1999-12-21 | Ethicon Endo-Surgery, Inc. | Method for using an electrosurgical device on lung tissue |
| US6161047A (en) | 1998-04-30 | 2000-12-12 | Medtronic Inc. | Apparatus and method for expanding a stimulation lead body in situ |
| US6045550A (en) | 1998-05-05 | 2000-04-04 | Cardiac Peacemakers, Inc. | Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions |
| DE19820240C2 (en) * | 1998-05-06 | 2002-07-11 | Erbe Elektromedizin | Electrosurgical instrument |
| US6493589B1 (en) | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
| US6241727B1 (en) | 1998-05-27 | 2001-06-05 | Irvine Biomedical, Inc. | Ablation catheter system having circular lesion capabilities |
| US5997534A (en) | 1998-06-08 | 1999-12-07 | Tu; Hosheng | Medical ablation device and methods thereof |
| US20070123958A1 (en) | 1998-06-10 | 2007-05-31 | Asthmatx, Inc. | Apparatus for treating airways in the lung |
| US7198635B2 (en) | 2000-10-17 | 2007-04-03 | Asthmatx, Inc. | Modification of airways by application of energy |
| US6119030A (en) | 1998-06-22 | 2000-09-12 | Ep Technologies, Inc. | Silicone tip for multiple electrode basket assemblies |
| US6066132A (en) | 1998-06-30 | 2000-05-23 | Ethicon, Inc. | Articulating endometrial ablation device |
| US6322559B1 (en) | 1998-07-06 | 2001-11-27 | Vnus Medical Technologies, Inc. | Electrode catheter having coil structure |
| US6029091A (en) | 1998-07-09 | 2000-02-22 | Irvine Biomedical, Inc. | Catheter system having lattice electrodes |
| US6296639B1 (en) | 1999-02-12 | 2001-10-02 | Novacept | Apparatuses and methods for interstitial tissue removal |
| US6129751A (en) | 1998-07-28 | 2000-10-10 | Intermedics Inc. | Cardiac lead with active fixation and biocompatible lubricant |
| US6322584B2 (en) | 1998-07-31 | 2001-11-27 | Surx, Inc. | Temperature sensing devices and methods to shrink tissues |
| US5992419A (en) | 1998-08-20 | 1999-11-30 | Mmtc, Inc. | Method employing a tissue-heating balloon catheter to produce a "biological stent" in an orifice or vessel of a patient's body |
| US5980563A (en) | 1998-08-31 | 1999-11-09 | Tu; Lily Chen | Ablation apparatus and methods for treating atherosclerosis |
| US6183468B1 (en) | 1998-09-10 | 2001-02-06 | Scimed Life Systems, Inc. | Systems and methods for controlling power in an electrosurgical probe |
| US6123703A (en) | 1998-09-19 | 2000-09-26 | Tu; Lily Chen | Ablation catheter and methods for treating tissues |
| US6036689A (en) | 1998-09-24 | 2000-03-14 | Tu; Lily Chen | Ablation device for treating atherosclerotic tissues |
| DE69924750T2 (en) | 1998-11-16 | 2006-03-02 | United States Surgical Corp., Norwalk | DEVICE FOR THE THERMAL TREATMENT OF TISSUE |
| US6375651B2 (en) * | 1999-02-19 | 2002-04-23 | Scimed Life Systems, Inc. | Laser lithotripsy device with suction |
| US6582427B1 (en) | 1999-03-05 | 2003-06-24 | Gyrus Medical Limited | Electrosurgery system |
| US6409723B1 (en) | 1999-04-02 | 2002-06-25 | Stuart D. Edwards | Treating body tissue by applying energy and substances |
| US6325797B1 (en) | 1999-04-05 | 2001-12-04 | Medtronic, Inc. | Ablation catheter and method for isolating a pulmonary vein |
| US6149647A (en) | 1999-04-19 | 2000-11-21 | Tu; Lily Chen | Apparatus and methods for tissue treatment |
| US6270476B1 (en) | 1999-04-23 | 2001-08-07 | Cryocath Technologies, Inc. | Catheter |
| CA2372430C (en) | 1999-06-05 | 2011-10-04 | Wilson-Cook Medical Inc. | Indicia for an endoscopic medical device |
| US6235024B1 (en) | 1999-06-21 | 2001-05-22 | Hosheng Tu | Catheters system having dual ablation capability |
| US6364878B1 (en) | 1999-07-07 | 2002-04-02 | Cardiac Pacemakers, Inc. | Percutaneous transluminal ablation catheter manipulation tool |
| US6200332B1 (en) | 1999-07-09 | 2001-03-13 | Ceramoptec Industries, Inc. | Device and method for underskin laser treatments |
| US7175644B2 (en) * | 2001-02-14 | 2007-02-13 | Broncus Technologies, Inc. | Devices and methods for maintaining collateral channels in tissue |
| US6749606B2 (en) | 1999-08-05 | 2004-06-15 | Thomas Keast | Devices for creating collateral channels |
| US6338836B1 (en) | 1999-09-28 | 2002-01-15 | Siemens Aktiengesellschaft | Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging |
| US20040249401A1 (en) | 1999-10-05 | 2004-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with a non-compliant balloon |
| US6645199B1 (en) | 1999-11-22 | 2003-11-11 | Scimed Life Systems, Inc. | Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same |
| US6529756B1 (en) | 1999-11-22 | 2003-03-04 | Scimed Life Systems, Inc. | Apparatus for mapping and coagulating soft tissue in or around body orifices |
| US6547776B1 (en) | 2000-01-03 | 2003-04-15 | Curon Medical, Inc. | Systems and methods for treating tissue in the crura |
| US6589235B2 (en) | 2000-01-21 | 2003-07-08 | The Regents Of The University Of California | Method and apparatus for cartilage reshaping by radiofrequency heating |
| US6723091B2 (en) | 2000-02-22 | 2004-04-20 | Gyrus Medical Limited | Tissue resurfacing |
| US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
| US6544226B1 (en) | 2000-03-13 | 2003-04-08 | Curon Medical, Inc. | Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body |
| US6770070B1 (en) * | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
| US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
| US7497844B2 (en) | 2000-03-31 | 2009-03-03 | Medtronic, Inc. | System and method for positioning implantable medical devices within coronary veins |
| US6673068B1 (en) | 2000-04-12 | 2004-01-06 | Afx, Inc. | Electrode arrangement for use in a medical instrument |
| US6640120B1 (en) | 2000-10-05 | 2003-10-28 | Scimed Life Systems, Inc. | Probe assembly for mapping and ablating pulmonary vein tissue and method of using same |
| US7104987B2 (en) * | 2000-10-17 | 2006-09-12 | Asthmatx, Inc. | Control system and process for application of energy to airway walls and other mediums |
| US6575623B2 (en) | 2000-11-10 | 2003-06-10 | Cardiostream, Inc. | Guide wire having extendable contact sensors for measuring temperature of vessel walls |
| US6869437B1 (en) | 2000-11-13 | 2005-03-22 | Cardica, Inc. | Method and system for performing closed-chest bypass |
| US6676657B2 (en) | 2000-12-07 | 2004-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Endoluminal radiofrequency cauterization system |
| US20020072737A1 (en) | 2000-12-08 | 2002-06-13 | Medtronic, Inc. | System and method for placing a medical electrical lead |
| US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
| US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
| US6699243B2 (en) | 2001-09-19 | 2004-03-02 | Curon Medical, Inc. | Devices, systems and methods for treating tissue regions of the body |
| US6647281B2 (en) | 2001-04-06 | 2003-11-11 | Scimed Life Systems, Inc. | Expandable diagnostic or therapeutic apparatus and system for introducing the same into the body |
| US6620159B2 (en) | 2001-06-06 | 2003-09-16 | Scimed Life Systems, Inc. | Conductive expandable electrode body and method of manufacturing the same |
| US6606521B2 (en) | 2001-07-09 | 2003-08-12 | Neuropace, Inc. | Implantable medical lead |
| US6802843B2 (en) | 2001-09-13 | 2004-10-12 | Csaba Truckai | Electrosurgical working end with resistive gradient electrodes |
| US7615049B2 (en) | 2001-09-19 | 2009-11-10 | Mederi Therapeutics, Inc. | Devices, systems and methods for treating tissue regions of the body |
| JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
| US6895267B2 (en) | 2001-10-24 | 2005-05-17 | Scimed Life Systems, Inc. | Systems and methods for guiding and locating functional elements on medical devices positioned in a body |
| US6669693B2 (en) | 2001-11-13 | 2003-12-30 | Mayo Foundation For Medical Education And Research | Tissue ablation device and methods of using |
| US20060205996A1 (en) | 2001-11-20 | 2006-09-14 | Solorant Medical, Inc. | Incontinence treatment with urethral guide |
| US6692492B2 (en) | 2001-11-28 | 2004-02-17 | Cardiac Pacemaker, Inc. | Dielectric-coated ablation electrode having a non-coated window with thermal sensors |
| US6709431B2 (en) * | 2001-12-18 | 2004-03-23 | Scimed Life Systems, Inc. | Cryo-temperature monitoring |
| US6893436B2 (en) | 2002-01-03 | 2005-05-17 | Afx, Inc. | Ablation instrument having a flexible distal portion |
| US20030153905A1 (en) * | 2002-01-25 | 2003-08-14 | Edwards Stuart Denzil | Selective ablation system |
| US6881213B2 (en) | 2002-06-28 | 2005-04-19 | Ethicon, Inc. | Device and method to expand treatment array |
| US6866662B2 (en) | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
| US6852110B2 (en) | 2002-08-01 | 2005-02-08 | Solarant Medical, Inc. | Needle deployment for temperature sensing from an electrode |
| US6858025B2 (en) * | 2002-08-06 | 2005-02-22 | Medically Advanced Designs, Llc | Cryo-surgical apparatus and method of use |
| CN100377685C (en) * | 2002-08-30 | 2008-04-02 | 奥林巴斯株式会社 | Medical treatment system, endoscope system, endoscope insert operation program, and endoscope device |
| US20040082947A1 (en) | 2002-10-25 | 2004-04-29 | The Regents Of The University Of Michigan | Ablation catheters |
| US20040153056A1 (en) | 2002-11-11 | 2004-08-05 | Berchtold Holding Gmbh, A German Corporation | Probe |
| US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
| US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
| US20050010138A1 (en) | 2003-07-11 | 2005-01-13 | Mangiardi Eric K. | Lumen-measuring devices and method |
| DE602004014283D1 (en) * | 2003-07-31 | 2008-07-17 | Wilson Cook Medical Inc | System for the introduction of several medical devices |
| US20050096644A1 (en) | 2003-10-30 | 2005-05-05 | Hall Jeffrey A. | Energy delivery optimization for RF duty cycle for lesion creation |
| JP4422472B2 (en) * | 2003-12-19 | 2010-02-24 | オリンパス株式会社 | Submucosa peeling treatment device and system |
| US9555223B2 (en) * | 2004-03-23 | 2017-01-31 | Medtronic Cryocath Lp | Method and apparatus for inflating and deflating balloon catheters |
| US7803150B2 (en) * | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
| WO2005112770A1 (en) * | 2004-05-13 | 2005-12-01 | Omnisonics Medical Technologies, Inc. | Ultrasonic medical device and method for treating urolithiasis |
| US7906124B2 (en) | 2004-09-18 | 2011-03-15 | Asthmatx, Inc. | Inactivation of smooth muscle tissue |
| US20060089637A1 (en) | 2004-10-14 | 2006-04-27 | Werneth Randell L | Ablation catheter |
| WO2006052940A2 (en) | 2004-11-05 | 2006-05-18 | Asthmatx, Inc. | Medical device with procedure improvement features |
| US7200445B1 (en) | 2005-10-21 | 2007-04-03 | Asthmatx, Inc. | Energy delivery devices and methods |
| US7949407B2 (en) | 2004-11-05 | 2011-05-24 | Asthmatx, Inc. | Energy delivery devices and methods |
| US20070093802A1 (en) | 2005-10-21 | 2007-04-26 | Danek Christopher J | Energy delivery devices and methods |
| AU2005304632C1 (en) * | 2004-11-12 | 2010-11-04 | Boston Scientific Scimed, Inc. | Improved energy delivery devices and methods |
| US20060135953A1 (en) | 2004-12-22 | 2006-06-22 | Wlodzimierz Kania | Tissue ablation system including guidewire with sensing element |
| US20060200121A1 (en) | 2005-03-03 | 2006-09-07 | Mowery Thomas M | Navigable, multi-positional and variable tissue ablation apparatus and methods |
| CA2605360C (en) | 2005-04-21 | 2017-03-28 | Asthmatx, Inc. | Control methods and devices for energy delivery |
| US20070287994A1 (en) * | 2006-06-12 | 2007-12-13 | Pankaj Amrit Patel | Endoscopically Introducible Expandable Bipolar Probe |
| US8235983B2 (en) | 2007-07-12 | 2012-08-07 | Asthmatx, Inc. | Systems and methods for delivering energy to passageways in a patient |
| US20090043301A1 (en) | 2007-08-09 | 2009-02-12 | Asthmatx, Inc. | Monopolar energy delivery devices and methods for controlling current density in tissue |
| CA2703414A1 (en) * | 2008-01-11 | 2009-07-16 | Boston Scientific Scimed, Inc. | Ablation devices and methods of use |
-
2006
- 2006-10-20 US US11/551,639 patent/US7931647B2/en active Active
-
2007
- 2007-10-08 EP EP20070843974 patent/EP2083734B1/en active Active
- 2007-10-08 JP JP2009533441A patent/JP5422389B2/en active Active
- 2007-10-08 CA CA2667009A patent/CA2667009C/en active Active
- 2007-10-08 ES ES07843974T patent/ES2398980T3/en active Active
- 2007-10-08 AU AU2007309319A patent/AU2007309319B2/en active Active
- 2007-10-08 WO PCT/US2007/080736 patent/WO2008051706A2/en active Application Filing
-
2011
- 2011-03-17 US US13/050,833 patent/US20110166565A1/en not_active Abandoned
-
2014
- 2014-12-17 US US14/572,979 patent/US20150105775A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7931647B2 (en) | 2011-04-26 |
| WO2008051706A2 (en) | 2008-05-02 |
| AU2007309319B2 (en) | 2013-01-24 |
| EP2083734A4 (en) | 2011-06-08 |
| JP5422389B2 (en) | 2014-02-19 |
| ES2398980T3 (en) | 2013-03-25 |
| JP2010506677A (en) | 2010-03-04 |
| US20080097424A1 (en) | 2008-04-24 |
| CA2667009C (en) | 2016-10-04 |
| US20150105775A1 (en) | 2015-04-16 |
| AU2007309319A1 (en) | 2008-05-02 |
| US20110166565A1 (en) | 2011-07-07 |
| EP2083734A2 (en) | 2009-08-05 |
| WO2008051706A3 (en) | 2008-06-26 |
| EP2083734B1 (en) | 2012-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007309319B2 (en) | Electrode markers and methods of use | |
| US11457974B2 (en) | Catheter having flexible tip with multiple flexible segments | |
| JP6165101B2 (en) | Microwave energy delivery device and system | |
| JP6437728B2 (en) | Microwave energy delivery device and system | |
| US6743226B2 (en) | Adjustable trans-urethral radio-frequency ablation | |
| DE60038581T2 (en) | INTEGRATED DEVICE FOR HEATING AND COOLING TISSUE | |
| JP5836964B2 (en) | Method and system for spinal radiofrequency nerve cutting | |
| US20120053485A1 (en) | Catheter Having Needle And Expandable Support Member And Methods Of Use | |
| BR112015002311B1 (en) | Electrical ablation device and method of treating tissue electrosurgically | |
| CN106413609A (en) | Bladder tissue modification for overactive bladder disorders | |
| CN109464187B (en) | Device and method for treating lung tumors | |
| EP1768591B1 (en) | Flexible endoscope for endo luminal access radio frequency tumor ablation | |
| CN110461261A (en) | Electrosurgical accesses sheath | |
| US20220313353A1 (en) | Ent instrument with rf electrodes on wire frame | |
| WO2024073765A2 (en) | Apparatus and methods for tissue ablation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |